<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><?covid-19-tdm ?><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">59633</article-id><article-id pub-id-type="doi">10.7554/eLife.59633</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-191104"><name><surname>Nelson</surname><given-names>Chase W</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6287-1598</contrib-id><email>cnelson@amnh.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-192414"><name><surname>Ardern</surname><given-names>Zachary</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9008-0897</contrib-id><email>zachary.ardern@tum.de</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-122777"><name><surname>Goldberg</surname><given-names>Tony L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3962-4913</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-186784"><name><surname>Meng</surname><given-names>Chen</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5968-6719</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-192415"><name><surname>Kuo</surname><given-names>Chen-Hao</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8454-0615</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-186787"><name><surname>Ludwig</surname><given-names>Christina</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6131-7322</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-192416"><name><surname>Kolokotronis</surname><given-names>Sergios-Orestis</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3309-8465</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-192417"><name><surname>Wei</surname><given-names>Xinzhu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8184-7016</contrib-id><email>aprilwei@berkeley.edu</email><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Biodiversity Research Center, Academia Sinica</institution><addr-line><named-content content-type="city">Taipei</named-content></addr-line><country>Taiwan</country></aff><aff id="aff2"><label>2</label><institution>Institute for Comparative Genomics, American Museum of Natural History</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Chair for Microbial Ecology, Technical University of Munich</institution><addr-line><named-content content-type="city">Freising</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution>Department of Pathobiological Sciences, University of Wisconsin-Madison</institution><addr-line><named-content content-type="city">Madison</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Global Health Institute, University of Wisconsin-Madison</institution><addr-line><named-content content-type="city">Madison</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technical University of Munich</institution><addr-line><named-content content-type="city">Freising</named-content></addr-line><country>Germany</country></aff><aff id="aff7"><label>7</label><institution>Department of Epidemiology and Biostatistics, School of Public Health, SUNY Downstate Health Sciences University</institution><addr-line><named-content content-type="city">Brooklyn</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution>Institute for Genomic Health, SUNY Downstate Health Sciences University</institution><addr-line><named-content content-type="city">Brooklyn</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution>Division of Infectious Diseases, Department of Medicine, SUNY Downstate Health Sciences University</institution><addr-line><named-content content-type="city">Brooklyn</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution>Departments of Integrative Biology and Statistics, University of California, Berkeley</institution><addr-line><named-content content-type="city">Berkeley</named-content></addr-line><country>United States</country></aff><aff id="aff11"><label>11</label><institution>Departments of Computer Science, Human Genetics, and Computational Medicine, University of California, Los Angeles</institution><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Rokas</surname><given-names>Antonis</given-names></name><role>Reviewing Editor</role><aff><institution>Vanderbilt University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Wittkopp</surname><given-names>Patricia J</given-names></name><role>Senior Editor</role><aff><institution>University of Michigan</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>01</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e59633</elocation-id><history><date date-type="received" iso-8601-date="2020-06-03"><day>03</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-09-30"><day>30</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Nelson et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Nelson et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-59633-v2.pdf"/><abstract><p>Understanding the emergence of novel viruses requires an accurate and comprehensive annotation of their genomes. Overlapping genes (OLGs) are common in viruses and have been associated with pandemics but are still widely overlooked. We identify and characterize <italic>ORF3d</italic>, a novel OLG in SARS-CoV-2 that is also present in Guangxi pangolin-CoVs but not other closely related pangolin-CoVs or bat-CoVs. We then document evidence of <italic>ORF3d</italic> translation, characterize its protein sequence, and conduct an evolutionary analysis at three levels: between taxa (21 members of <italic>Severe acute respiratory syndrome-related coronavirus</italic>), between human hosts (3978 SARS-CoV-2 consensus sequences), and within human hosts (401 deeply sequenced SARS-CoV-2 samples). <italic>ORF3d</italic> has been independently identified and shown to elicit a strong antibody response in COVID-19 patients. However, it has been misclassified as the unrelated gene <italic>ORF3b</italic>, leading to confusion. Our results liken <italic>ORF3d</italic> to other accessory genes in emerging viruses and highlight the importance of OLGs.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>genome annotation</kwd><kwd>natural selection</kwd><kwd>ORF3d</kwd><kwd>overlapping genes</kwd><kwd>pandemic</kwd><kwd>SARS-CoV-2</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Virus</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001869</institution-id><institution>Academia Sinica</institution></institution-wrap></funding-source><award-id>Postdoctoral Research Fellowship</award-id><principal-award-recipient><name><surname>Nelson</surname><given-names>Chase W</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001263</institution-id><institution>National Philanthropic Trust</institution></institution-wrap></funding-source><award-id>Grant</award-id><principal-award-recipient><name><surname>Ardern</surname><given-names>Zachary</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007015</institution-id><institution>University of Wisconsin-Madison</institution></institution-wrap></funding-source><award-id>John D MacArthur Professorship Chair</award-id><principal-award-recipient><name><surname>Goldberg</surname><given-names>Tony L</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>IOS grants #1755370 and #1758800</award-id><principal-award-recipient><name><surname>Kolokotronis</surname><given-names>Sergios-Orestis</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A novel, overlapping, putatively functional gene in SARS-CoV-2, <italic>ORF3d</italic>, is absent from close relatives of SARS-CoV-2 and may have contributed to the biology, emergence, or spread of the virus.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The COVID-19 pandemic raises urgent questions about the properties that allow animal viruses to cross species boundaries and spread within humans. Addressing these questions requires an accurate and comprehensive understanding of viral genomes. One frequently overlooked source of novelty is the evolution of new overlapping genes (OLGs), wherein a single stretch of nucleotides encodes two distinct proteins in different reading frames. Such ‘genes within genes’ compress genomic information and allow genetic innovation via <italic>overprinting</italic> (<xref ref-type="bibr" rid="bib46">Keese and Gibbs, 1992</xref>), particularly as frameshifted sequences preserve certain physicochemical properties of proteins (<xref ref-type="bibr" rid="bib3">Bartonek et al., 2020</xref>). However, OLGs also entail the cost that a single mutation may alter two proteins, constraining evolution of the pre-existing open reading frame (ORF) and complicating sequence analysis. Unfortunately, genome annotation methods typically miss OLGs, instead favoring one ORF per genomic region (<xref ref-type="bibr" rid="bib84">Warren et al., 2010</xref>).</p><p>OLGs are known entities but remain inconsistently reported in viruses of the species <italic>Severe acute respiratory syndrome-related coronavirus</italic> (subgenus <italic>Sarbecovirus</italic>; genus <italic>Betacoronavirus</italic>; <xref ref-type="bibr" rid="bib16">Coronaviridae Study Group of the International Committee on Taxonomy of Viruses et al., 2020</xref>). For example, annotations of <italic>ORF9b</italic> and <italic>ORF9c</italic> are absent or conflicting in SARS-CoV-2 reference genome Wuhan-Hu-1 (NCBI: NC_045512.2) and genomic studies (e.g. <xref ref-type="bibr" rid="bib14">Chan et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Wu et al., 2020b</xref>), and OLGs are often not displayed in genome browsers (e.g. <xref ref-type="bibr" rid="bib26">Flynn et al., 2020</xref>). Further, <italic>ORF3b</italic>, an extensively characterized OLG within <italic>ORF3a</italic> that is present in other species members including SARS-CoV (SARS-CoV-1) (<xref ref-type="bibr" rid="bib58">McBride and Fielding, 2012</xref>), has sometimes been annotated in SARS-CoV-2 even though it contains four early STOP codons in this virus. Such inconsistencies complicate research, because OLGs may play key roles in the emergence of new viruses. For example, in human immunodeficiency virus-1 (HIV-1), the novel OLG <italic>asp</italic> within <italic>env</italic> is actively expressed in human cells (<xref ref-type="bibr" rid="bib1">Affram et al., 2019</xref>) and is associated with the pandemic M group lineage (<xref ref-type="bibr" rid="bib13">Cassan et al., 2016</xref>).</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Novel overlapping gene candidates</title><p>To identify novel OLGs within the SARS-CoV-2 genome, we first generated a list of candidate overlapping ORFs in the Wuhan-Hu-1 reference genome (NCBI: NC_045512.2). Specifically, we used the codon permutation method of <xref ref-type="bibr" rid="bib77">Schlub et al., 2018</xref> to detect unexpectedly long ORFs while controlling for codon usage. One unannotated OLG candidate, here named <italic>ORF3d</italic>, scored highly (p=0.0104), exceeding the significance of two known OLGs annotated in Uniprot (<italic>ORF9b</italic> and <italic>ORF9c</italic>, both within <italic>N</italic>; <ext-link ext-link-type="uri" xlink:href="https://viralzone.expasy.org/8996">https://viralzone.expasy.org/8996</ext-link>) (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Gene repertoire and evolutionary relationships of <italic>Severe acute respiratory syndrome-related coronavirus</italic> species members.</title><p>Only genes downstream of <italic>ORF1ab</italic> are shown, beginning with the Spike gene <italic>S</italic>. (<bold>A</bold>) Four types of genes and their relative positions in the SARS-CoV-2 Wuhan-Hu-1 genome (NCBI: NC_045512.2). Genes are colored by type: novel overlapping genes (OLGs) (gold; <italic>ORF3d</italic> only); conserved OLGs (burgundy); accessory (green); and structural (blue). Note that <italic>ORF3b</italic> has been truncated relative to SARS-CoV genomes, whereas <italic>ORF8</italic> remains intact (i.e. has not been split into <italic>ORF8a</italic> and <italic>ORF8b</italic>). (<bold>B</bold>) Genes with intact ORFs in each of 21 <italic>Severe acute respiratory syndrome-related coronavirus</italic> genomes. Gene positions are shown relative to each genome, i.e. homologous genes are not precisely aligned. Only the full-length isoforms of <italic>ORF3a</italic> and <italic>ORF3d</italic> are shown (for shorter isoforms, see <xref ref-type="table" rid="table1">Table 1</xref>). Note that the first 20 codons of <italic>ORF3d</italic> overlap the last codons of <italic>ORF3c</italic> (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), such that the beginning of <italic>ORF3d</italic> involves a triple overlap (<italic>ORF3a</italic>/<italic>ORF3c</italic>/<italic>ORF3d</italic>). <italic>ORF3b</italic> is full-length in only three sequences (SARS-CoV TW11, SARS-CoV Tor2, and bat-CoV Rs7327), while the remaining sequences have premature STOP codons (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). <italic>ORF8</italic> is not novel in SARS-CoV-2 (contra <xref ref-type="bibr" rid="bib14">Chan et al., 2020</xref>), but is intact in all but five sequences (split into <italic>ORF8a</italic> and <italic>ORF8b</italic> in SARS-CoVs TW11 and Tor2; deleted in bat-CoVs BtKY72, BM48-31, and JTMC15). <italic>ORF9b</italic> and <italic>ORF9c</italic> are found throughout this virus species, yet rarely annotated in genomes at NCBI.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>SARS-related-CoV_ALN.fasta.</title><p>Whole-genome multiple sequence alignment of 21 genomes of the species <italic>Severe acute respiratory syndrome-related coronavirus</italic>. Note that the pangolin-CoV GD/1 sequence has been masked as N (license constraint), but can be acquired with GISAID registration.</p></caption><media mime-subtype="plain" mimetype="text" xlink:href="elife-59633-fig1-data1-v2.fasta.txt"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>SARS-related-CoV_ALN.gtf.txt.</title><p>Gene Transfer Format (GTF) file giving gene positions within SARS-related-CoV_ALN.fasta. Genes were extracted and gaps removed from each sequence before displaying.</p></caption><media mime-subtype="plain" mimetype="text" xlink:href="elife-59633-fig1-data2-v2.gtf.txt"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Codon permutation analysis to identify candidate overlapping genes in all three forward-strand reading frames of the SARS-CoV-2 genome.</title><p>Genome positions of known and hypothesized genes are indicated with horizontal red lines. Reading frames 1, 2, and 3 begin at positions 1, 2, or 3 of the Wuhan-Hu-1 reference genome, respectively, with genome coordinates shown at the bottom (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Yellow indicates low p-values (natural logarithm scale), while gray indicates absence of a STOP-to-STOP ORF longer than 30 codons or presence outside of an annotated non-overlapping gene (not tested). Note that low p-values are expected for the non-overlapping genes. Only the first of four SARS-CoV-2 ORFs homologous to <italic>ORF3b</italic> is shown (<xref ref-type="fig" rid="fig4">Figure 4</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig1-figsupp1-v2.tif"/></fig></fig-group><p><italic>ORF3d</italic> comprises 58 codons (including STOP) near the beginning of <italic>ORF3a</italic> (<xref ref-type="table" rid="table1">Table 1</xref>), making it longer than the known genes <italic>ORF7b</italic> (44 codons) and <italic>ORF10</italic> (39 codons) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). <italic>ORF3d</italic> was discovered independently by <xref ref-type="bibr" rid="bib14">Chan et al., 2020</xref> as ‘<italic>ORF3b</italic>’ and <xref ref-type="bibr" rid="bib69">Pavesi, 2020</xref> as ‘hypothetical protein’. Due to this naming ambiguity and its location within <italic>ORF3a</italic>, <italic>ORF3d</italic> has subsequently been conflated with the previously documented <italic>ORF3b</italic> in multiple studies (e.g. <xref ref-type="bibr" rid="bib28">Fung et al., 2020</xref>; <xref ref-type="bibr" rid="bib30">Ge et al., 2020</xref>; <xref ref-type="bibr" rid="bib32">Gordon et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Hachim et al., 2020</xref>; <xref ref-type="bibr" rid="bib37">Helmy et al., 2020</xref>; <xref ref-type="bibr" rid="bib91">Yi et al., 2020</xref>). Critically, <italic>ORF3d</italic> is unrelated (i.e. not homologous) to <italic>ORF3b</italic>, as the two genes occupy different genomic positions within <italic>ORF3a: ORF3d</italic> ends 39 codons upstream of the genome region homologous to <italic>ORF3b</italic>, and the <italic>ORF3b</italic> start site encodes only 23 codons in SARS-CoV-2 due to a premature STOP (<xref ref-type="bibr" rid="bib89">Wu et al., 2020a</xref>; <xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Furthermore, the two genes occupy different reading frames: codon position 1 of <italic>ORF3a</italic> overlaps codon position 2 of <italic>ORF3d</italic> (frame ss12) but codon position 3 of <italic>ORF3b</italic> (frame ss13). <italic>ORF3d</italic> is also distinct from other OLGs hypothesized within <italic>ORF3a</italic> (<xref ref-type="table" rid="table1">Table 1</xref>). Thus, <italic>ORF3d</italic> putatively encodes a novel protein not present in previously discovered <italic>Severe acute respiratory syndrome-related coronavirus</italic> genomes, while the absence of full-length <italic>ORF3b</italic> in SARS-CoV-2 distinguishes it from SARS-CoV (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Nomenclature and reading frames for overlapping gene candidates in SARS-CoV-2 <italic>ORF3a</italic>.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Gene<sup>*</sup></th><th valign="top">Reading frame<sup>†</sup></th><th valign="top">Genome positions, Wuhan-Hu-1 <break/>(CDS positions, <italic>ORF3a</italic>)<sup>‡</sup></th><th valign="top">Length</th><th valign="top">Description</th><th valign="top">References</th></tr></thead><tbody><tr><td valign="top"><italic>ORF3a</italic></td><td valign="top">ss11 (reference)</td><td valign="top">25393–26220 <break/>(1-828)</td><td valign="top">276 codons <break/>(828 nt)</td><td valign="top">Ion channel formation and virus release in SARS-CoV infection; host cell apoptosis; triggers inflammation; antagonizes interferon</td><td valign="top"><xref ref-type="bibr" rid="bib57">Lu et al., 2010</xref>; <xref ref-type="bibr" rid="bib18">Cui et al., 2019</xref></td></tr><tr><td valign="top"><italic>ORF3c</italic></td><td valign="top">ss13</td><td valign="top">25457–25582 <break/>(65-190)</td><td valign="top">42 codons <break/>(126 nt)</td><td valign="top">Features suggestive of a viroporin (<xref ref-type="bibr" rid="bib11">Cagliani et al., 2020</xref>); lowest <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub> ratio estimated for any gene in our between-host selection analysis (<xref ref-type="fig" rid="fig5">Figure 5</xref>); overlaps codons 22–64 of <italic>ORF3a</italic></td><td valign="top">First discovered by <xref ref-type="bibr" rid="bib11">Cagliani et al., 2020</xref> as <italic>ORF3h</italic>; <italic>ORF3c</italic> in <xref ref-type="bibr" rid="bib25">Firth, 2020</xref>; <italic>ORF3c</italic> in <xref ref-type="bibr" rid="bib43">Jungreis et al., 2020</xref>; <italic>ORF3a.iORF1</italic> in <xref ref-type="bibr" rid="bib24">Finkel et al., 2020</xref>; <italic>ORF3b</italic> in <xref ref-type="bibr" rid="bib69">Pavesi, 2020</xref></td></tr><tr><td valign="top"><italic>ORF3d</italic></td><td valign="top">ss12</td><td valign="top">25524–25697 <break/>(132-305)</td><td valign="top">58 codons <break/>(174 nt)</td><td valign="top">Aligned to and named <italic>ORF3b</italic> by <xref ref-type="bibr" rid="bib14">Chan et al., 2020</xref> but is not homologous to <italic>ORF3b</italic>; interferon antagonism has not been demonstrated; binds STOML2 mitochondrial protein (<xref ref-type="bibr" rid="bib32">Gordon et al., 2020</xref>); contains a predicted signal peptide in the region encoding <italic>ORF3d-2</italic>; contains an <italic>X</italic> motif in pangolin-CoV but not SARS-CoV-2 (<xref ref-type="bibr" rid="bib60">Michel et al., 2020</xref>); may contribute to differences between SARS-CoV and SARS-CoV-2 in immune response as a unique antigenic target (<xref ref-type="bibr" rid="bib36">Hachim et al., 2020</xref>; Niloufar Kavian, pers. comm.); overlaps codons 44–102 of <italic>ORF3a</italic></td><td valign="top">Present study; first discovered by <xref ref-type="bibr" rid="bib14">Chan et al., 2020</xref> but misclassified as <italic>ORF3b</italic>; <italic>ORF3b</italic> in <xref ref-type="bibr" rid="bib32">Gordon et al., 2020</xref>, <xref ref-type="bibr" rid="bib36">Hachim et al., 2020</xref>, and citing studies; ‘hypothetical protein’ in <xref ref-type="bibr" rid="bib69">Pavesi, 2020</xref>; ‘a completely different ORF’ in <xref ref-type="bibr" rid="bib60">Michel et al., 2020</xref></td></tr><tr><td valign="top"><italic>ORF3d-2</italic></td><td valign="top">ss12</td><td valign="top">25596–25697 <break/>(204-305)</td><td valign="top">34 codons <break/>(102 nt)</td><td valign="top">A shorter isoform of <italic>ORF3d</italic> that starts after the first 24 codons, where the majority of premature STOP codons in SARS-CoV-2 are located; contains a predicted signal peptide (<xref ref-type="bibr" rid="bib24">Finkel et al., 2020</xref>); likely expressed at higher levels than full-length <italic>ORF3d</italic> (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) overlaps codons 68–102 of <italic>ORF3a</italic></td><td valign="top">Discovered by <xref ref-type="bibr" rid="bib24">Finkel et al., 2020</xref> as <italic>ORF3a-iORF2</italic></td></tr><tr><td valign="top"><italic>ORF3a-2</italic></td><td valign="top">ss11 (reference)</td><td valign="top">25765–26220 <break/>(373-828)</td><td valign="top">152 codons <break/>(456 nt)</td><td valign="top">A shorter isoform of <italic>ORF3a</italic> that starts after the first 124 codons; evidence of expression separate from that of <italic>ORF3a</italic> (<xref ref-type="bibr" rid="bib20">Davidson et al., 2020</xref>); has also been conflated with <italic>ORF3b</italic>; equivalent to codons 124–276 of <italic>ORF3a</italic></td><td valign="top">Discovered by <xref ref-type="bibr" rid="bib20">Davidson et al., 2020</xref> (pers. comm.) but referred to as <italic>ORF3b</italic></td></tr><tr><td valign="top"><italic>ORF3b</italic> region<sup>§</sup></td><td valign="top">ss13</td><td valign="top">25814–26281; four ORFs at 25814–82, 25910–84, 26072–170, and 26183–281 (422-889; ORFs at 422–90, 518–92, 680–778, and 791–889)</td><td valign="top">156 codons <break/>(468 nt); the four ORFs are 23, 25, 33, and 33 codons <break/>(69, 75, 99, and 99 nt)</td><td valign="top">Full-length in some related viruses, but truncated by multiple in-frame STOP codons in SARS-CoV-2; longer forms function as an interferon antagonist in SARS-related viruses; may contribute to differences between SARS-CoV and SARS-CoV-2 in immune response; although aligned to <italic>ORF3d</italic> by <xref ref-type="bibr" rid="bib14">Chan et al., 2020</xref>, the two are not homologous; overlaps codons 141–276 of <italic>ORF3a</italic> (first ORF overlaps codons 141–164)</td><td valign="top"><xref ref-type="bibr" rid="bib47">Konno et al., 2020</xref> claim functionality for the first (23-codon) ORF in SARS-CoV-2; the first ORF is also mentioned by <xref ref-type="bibr" rid="bib89">Wu et al., 2020a</xref></td></tr></tbody></table><table-wrap-foot><fn><p><sup>*</sup>Genes are listed by position of start site in the genome from 5′ (top) to 3′ (bottom).</p><p><sup>†</sup>Nomenclature as described in <xref ref-type="bibr" rid="bib85">Wei and Zhang, 2015</xref> and <xref ref-type="bibr" rid="bib64">Nelson et al., 2020a</xref>: ss = sense-sense (same strand); ss12 = codon position 1 of the reference frame overlaps codon position 2 of the overlapping frame on the same strand; ss13 = codon position 1 of the reference frame overlaps codon position 3 of the overlapping frame on the same strand. Frame is indicated from the perspective of <italic>ORF3a</italic> as the reference gene, i.e. <italic>ORF3d</italic> starts at codon position 3 of <italic>ORF3a</italic>, while <italic>ORF3c</italic> and <italic>ORF3b</italic> start at codon position 2 of <italic>ORF3a</italic>.</p></fn><fn><p><sup>‡</sup>Positions and counts include STOP codons. Positions or sequences were indicated by the original publications or verified by personal communication if ambiguous.</p><p><sup>§</sup>The SARS-CoV-2 region homologous to <italic>ORF3b</italic> of SARS-CoV contains four premature STOP codons and four distinct ORFs (AUG-to-STOP); see <xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig6">Figure 6</xref>, and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title><italic>ORF3d</italic> molecular biology and expression</title><p>To assess the expression of <italic>ORF3d</italic>, we re-analyzed the SARS-CoV-2 ribosome profiling (Ribo-seq) data of <xref ref-type="bibr" rid="bib24">Finkel et al., 2020</xref>. This approach allows the study of gene expression and reading frame at single nucleotide (nt) resolution by sequencing mRNA fragments bound by actively translating ribosomes (ribosome footprints) (<xref ref-type="bibr" rid="bib41">Ingolia et al., 2009</xref>). To do this, we focused on samples with reads reliably associated with ribosomes stalled at translation start sites, i.e. lactimidomycin and harringtonine treatments at 5 hr post-infection. After trimming reads to their 5′ ends (first nt), we observe a consistent peak in read depth ~12 nt upstream of the start site of <italic>ORF3d</italic> (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), the expected ribosomal P-site offset (<xref ref-type="bibr" rid="bib12">Calviello and Ohler, 2017</xref>). Similar peaks are also observed for previously annotated genes (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>SARS-CoV-2 gene expression in ribosome profiling and mass spectrometry datasets.</title><p>Ribosome profiling (Ribo-seq) data were obtained from <xref ref-type="bibr" rid="bib24">Finkel et al., 2020</xref>; mass spectrometry data were obtained from <xref ref-type="bibr" rid="bib20">Davidson et al., 2020</xref> and <xref ref-type="bibr" rid="bib7">Bezstarosti et al., 2020</xref>. Reads were trimmed to their first (5′) nucleotide to minimize statistical dependence while preserving reading frame. Results are shown after pooling samples treated with harringtonine (SRR11713360, SRR11713361) or lactimidomycin (SRR11713358, SRR11713359) at 5 hr post-infection. (<bold>A</bold>) Ribosome profiling coverage (read depth) near translation initiation sites, measured as mean reads per million mapped reads. Only reads of length 29–31 nucleotides were used, chosen for their enrichment at the start sites of highly expressed annotated genes (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>). Light blue backgrounds denote fully (internal) overlapping genes. Annotated genes show an accumulation of 5′ ends of protected reads upstream of the gene’s start site (vertical gray dotted lines), peaking near the ribosome P-site offset of −12 nt (red = maximum depth). Distributions are largely consistent across individual samples (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). The ranges of the y-axes vary according to expression level, with the most highly expressed gene (<italic>N</italic>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>) having the largest range. (<bold>B</bold>) Correlation between protein expression as estimated by mass spectrometry and ribosomal profiling. ‘iBAQ prop’ refers to the relative (proportion of maximum) protein intensity-based absolute quantification (iBAQ) value (<xref ref-type="bibr" rid="bib78">Schwanhäusser et al., 2011</xref>). Genes are denoted by shape and ordinally colored by iBAQ prop from high (red) to low (blue). ‘Upstream peak’ refers to the maximum read depth observed at the approximate P-site offset (red bars in <bold>A</bold>), while mean read depths were measured across each gene using 30 nt reads separately for in-frame (codon position 1) and out-of-frame (codon positions 2 and 3) sites (non-overlapping gene regions only, except for <italic>ORF9b</italic>). (<bold>C</bold>) Reading frame of ribosome profiling reads in the <italic>ORF3c</italic>/<italic>ORF3d</italic> region of <italic>ORF3a</italic>. Solid lines show the fraction of reads in each frame, summed across samples in sliding windows of 30 nt (step size = 1 nt; read length = 30 nt). Color denotes frame: green = reference frame (<italic>ORF3a</italic>); burgundy = ss13, the forward-strand frame encoding <italic>ORF3c</italic>, whose codon position 3 overlaps codon position 1 of <italic>ORF3a</italic>; and gold = ss12, the forward-strand frame encoding <italic>ORF3d</italic>, whose codon position 2 overlaps codon position 1 of <italic>ORF3a</italic>. Values are shown for the central nucleotide of each window, with shaded regions corresponding to 95% binomial confidence intervals. Alternative frame translation is suggested where a given frame (solid line) exceeds its average across the remainder of the gene (horizontal dashed line; non-OLG regions of <italic>ORF3a</italic>). Vertical gray dotted lines indicate gene start and end sites. Gray bars show read depth for each window, with a maximum of 2889 reads at genome position 25442.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>riboseq_upstream_peaks.txt.</title><p>Source data for <xref ref-type="fig" rid="fig2">Figure 2A</xref>.</p></caption><media mime-subtype="plain" mimetype="text" xlink:href="elife-59633-fig2-data1-v2.txt"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>expression_data_by_gene_frame.txt.</title><p>Source data for <xref ref-type="fig" rid="fig2">Figure 2B</xref>.</p></caption><media mime-subtype="plain" mimetype="text" xlink:href="elife-59633-fig2-data2-v2.txt"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>riboseq_ORF3d_sliding_window.txt.</title><p>Source data for <xref ref-type="fig" rid="fig2">Figure 2C</xref>.</p></caption><media mime-subtype="plain" mimetype="text" xlink:href="elife-59633-fig2-data3-v2.txt"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Ribosome profiling coverage near translation initiation sites for individual samples.</title><p>Details as in <xref ref-type="fig" rid="fig2">Figure 2A</xref>, except samples were not pooled and genes are arranged vertically by start site in the genome from 5′ to 3′ (top to bottom). Treatments are indicated as Harr = harringtonine and LTM = lactimidomycin at 5 hr post-infection (hpi).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Correlation between protein expression as estimated by mass spectrometry and ribosomal profiling, for individual treatments and codon positions.</title><p>Details as in <xref ref-type="fig" rid="fig2">Figure 2B</xref>, except estimates are shown for all sites in a gene (All frames) and out-of-frame reads are shown separately for codon positions (Codon pos) 2 and 3. <italic>ORF9b</italic> is a fully (internal) overlapping gene occurring within <italic>N</italic>, with codon position 3 of <italic>ORF9b</italic> corresponding to codon position 1 of <italic>N</italic> (i.e. frame ss13 of <italic>N</italic>). As a result, codon position 3 of <italic>ORF9b</italic> is predominantly occupied by ribosomes translating <italic>N</italic>, the most highly expressed gene, leading to overestimation of <italic>ORF9b</italic> expression (Codon pos 3; right). Ribosome profiling read depth at codon position 1 exhibits a marginal Spearman’s rank correlation with mass spectrometry for cycloheximide (CHX), harringtonine (Harr), and lactimidomycin (LTM) treatments; however, as expected, all correlations for RNA-seq (mRNA), as well as reads mapping to other codon positions, were not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Reading frames occupied by the 5′ ends of ribosome profiling reads as a function of read length.</title><p>Processed, aligned reads from <xref ref-type="bibr" rid="bib24">Finkel et al., 2020</xref> were trimmed to their 5′ ends (first nt). Fractions of reads mapping to each codon position (x-axis) are shown as a function of read length (y-axis; 26–32 nt) after pooling samples according to treatment (CHX = cycloheximide, Harr = harringtonine, LTM = lactimidomycin, mRNA = RNA seq) and time (hours post-infection; hpi). Codon position is defined relative to gene start sites of annotated non-overlapping genes, excluding any overlapping gene regions. Gray bars show relative total counts for reads of different lengths, with different scales for 5 hpi (lower coverage; max = 284,608 reads at CHX/30nt) and 24 hpi (higher coverage; max = 3,149,251 reads at Harr/29nt). At 5 hpi, reads of length 29 and 30 nt tend to have 5′ ends mapping to the correct protein-coding reading frame (codon position 1) of the gene in which they occur, and also tend to be most abundant, as expected given the size of ribosome-protected fragments (~30 nt). Samples from 24 hpi have flatter (left-shifted) read length distributions and no clear frame signal. The horizontal dashed gray line corresponds to the expectation for RNA fragments not protected by ribosomes, that is 33% of reads mapping to each codon position (random).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig2-figsupp3-v2.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Ribosome profiling read accumulation at gene start sites as a function of read length.</title><p>Points indicate the percentage of all reads in the region shown whose first nucleotides (5′ ends) map to each genome position, colored according to read length. In each case, the longer read lengths have 5′ ends that predominate at approximately −12 nt from the gene start site (horizontal dashed lines, right), corresponding to the ribosome P-site offset (center of yellow highlighted region). A peak in total read depth (gray bars) is also observed at this position, as seen in <xref ref-type="fig" rid="fig2">Figure 2A</xref>. Highly expressed non-overlapping (<italic>N</italic>, <italic>M</italic>, <italic>S</italic>, and <italic>ORF7b</italic>) and overlapping (<italic>ORF9b</italic>) genes are shown on the left, while <italic>ORF3a</italic> and its hypothesized overlapping genes are shown on the right. Note that <italic>ORF9b</italic> begins shortly after <italic>N</italic>, such that the upstream peak of <italic>N</italic> occurs at position −22 nt relative to the start site of <italic>ORF9b</italic>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig2-figsupp4-v2.tif"/></fig><fig id="fig2s5" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 5.</label><caption><title>Reading frame of ribosome profiling reads in the <italic>ORF3c</italic>/<italic>ORF3d</italic> region of <italic>ORF3a</italic> for individual treatments.</title><p>Details as in <xref ref-type="fig" rid="fig2">Figure 2C</xref>, except results are shown separately after pooling the two biological replicates for each treatment (CHX = cycloheximide, Harr = harringtonine, LTM = lactimidomycin, mRNA = RNA seq) (<xref ref-type="bibr" rid="bib24">Finkel et al., 2020</xref>). Genes and their reading frames are denoted by color according to <xref ref-type="fig" rid="fig1">Figure 1</xref>, with Frames 1, 2, and 3 corresponding to the frames beginning at codon positions 1, 2, and 3 of <italic>ORF3a</italic>, respectively. Clear evidence for translation in the appropriate reading frame is observed for <italic>ORF3c</italic> (burgundy) and <italic>ORF3d</italic>/<italic>ORF3d-2</italic> (gold). The status of the first half of <italic>ORF3d</italic> is obscured by the signal of <italic>ORF3c</italic>, but the increase in Frame 1 (<italic>ORF3a</italic>) reads and drop in proportion of Frame 2 (<italic>ORF3c</italic>) reads at the start of <italic>ORF3d</italic> is suggestive of an otherwise-unexpected biological change at this locus.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig2-figsupp5-v2.tif"/></fig><fig id="fig2s6" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 6.</label><caption><title>Reading frame of ribosome profiling reads in the <italic>ORF3c</italic>/<italic>ORF3d</italic> region of <italic>ORF3a</italic> for individual treatments using a smaller sliding window size of 19 nt.</title><p>Details as in <xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5</xref>, except results are shown for a sliding window size of 19 nt (step size = 1 nt).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig2-figsupp6-v2.tif"/></fig><fig id="fig2s7" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 7.</label><caption><title>Reading frame of ribosome profiling reads in the <italic>N</italic>/<italic>ORF9b</italic>/<italic>ORF9c</italic> region.</title><p>Details as in <xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5</xref>, except Frames 1, 2, and 3 correspond to the frames beginning at positions 1, 2, and 3 of the Wuhan-Hu-1 reference genome, respectively. Expression of <italic>ORF9b</italic> is evidenced by a peak in the fraction of reads mapping to Frame 3 (burgundy) at the appropriate region, as well as a peak in read depth (gray bars) immediately upstream (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Translational status of <italic>ORF9c</italic> is ambiguous, with minimal enrichment of reads in the appropriate frame (burgundy) along the gene.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig2-figsupp7-v2.tif"/></fig><fig id="fig2s8" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 8.</label><caption><title>Reading frame of ribosome profiling reads in the full <italic>ORF3a</italic> gene.</title><p>Details as in <xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5</xref>. No clear evidence is observed for the expression of any of the <italic>ORF3b</italic> ORFs present in SARS-CoV-2, but the translational status of these ORFs requires further investigation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig2-figsupp8-v2.tif"/></fig><fig id="fig2s9" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 9.</label><caption><title>Reading frame of ribosome profiling reads in the <italic>ORF3c</italic>/<italic>ORF3d</italic> region of <italic>ORF3a</italic> for reads of length 29 nt.</title><p>Details as in <xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5</xref>, except results are shown for reads of length 29 nt, which are also indicative of frame but have slightly lower coverage (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>) and exhibit frame-related periodicity. Evidence for <italic>ORF3c</italic> (Frame 2; burgundy) is more pronounced using this read length, while the peak for <italic>ORF3d</italic> (Frame 3; gold) occurs slightly later, overlapping <italic>ORF3d-2</italic>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig2-figsupp9-v2.tif"/></fig></fig-group><p>To investigate the relationship between ribosome profiling read depth and expressed protein levels, we re-analyzed five publicly available SARS-CoV-2 mass spectrometry (MS) datasets (<xref ref-type="bibr" rid="bib7">Bezstarosti et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Bojkova et al., 2020</xref>; <xref ref-type="bibr" rid="bib20">Davidson et al., 2020</xref>; PRIDE Project PXD018581; <xref ref-type="bibr" rid="bib94">Zecha et al., 2020</xref>; Materials and methods). We were unable to detect ORF3c, ORF3d, ORF3b, ORF9c, or ORF10 when employing a 1% false-discovery threshold. This result may reflect the limitations of MS for detecting proteins that are very short, weakly expressed under the specific conditions tested, or lack detectable peptides; for example, even the envelope protein E is not detected in some SARS-CoV-2 datasets (<xref ref-type="bibr" rid="bib8">Bojkova et al., 2020</xref>; <xref ref-type="bibr" rid="bib20">Davidson et al., 2020</xref>). However, we do find a strong correlation between protein expression as estimated from MS and the ribosome profiling read depth observed at upstream peaks, with <italic>r</italic><sub>S</sub> = 0.89 (p=0.0004, Spearman’s rank) (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). This suggests that the presence and depth of an upstream peak is a reliable indicator of expression. Specifically, results from both proteomic and ribosome profiling approaches confirm that N, M, and S are the most highly expressed proteins, with N constituting ~80% of the total viral protein content. We also observe that the number of reads determined to be in the correct reading frame (codon position 1) along the gene is moderately correlated with MS expression values (<italic>r</italic><sub>S</sub> = 0.60, p=0.056), while this is not true for out-of-frame (codon position 2 and 3) reads (<italic>r</italic><sub>S</sub> = 0.39, p=0.237) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>).</p><p>Ribosome profiling reads have a strong tendency to map with their first nucleotide occupying a particular codon position (i.e. in-frame) (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). We therefore examined codon position mapping across <italic>ORF3a</italic> to explore whether the proportions of reads in alternative frames are higher in the <italic>ORF3c</italic>/<italic>ORF3d</italic> region. Analyses were limited to reads of length 30 nt, the expected size of ribosome-bound fragments, which exhibit positioning indicative of the correct reading frame (codon position 1) of annotated genes, as well as the highest total coverage (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>, <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>). Sliding windows reveal a peak in the fraction of reads mapping to the reading frame of <italic>ORF3d</italic> at its hypothesized locus, with this frame’s maximum occurring at the center of <italic>ORF3d</italic>, co-located with a dip in the fraction of reads mapping to the frame of <italic>ORF3a</italic> (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). These observations are reproducible across treatments (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5</xref>), robust to sliding window size (<xref ref-type="fig" rid="fig2s6">Figure 2—figure supplement 6</xref>), and similar to the reading frame perturbations observed for the OLG <italic>ORF9b</italic> within <italic>N</italic> (<xref ref-type="fig" rid="fig2s7">Figure 2—figure supplement 7</xref>). At the same time, the <italic>ORF3d</italic> peak stands in contrast to the remainder of <italic>ORF3a</italic>, where the reading frame of <italic>ORF3a</italic> predominates, and smaller peaks in the frame of <italic>ORF3d</italic> are not accompanied by a large dip in the frame of <italic>ORF3a</italic> (<xref ref-type="fig" rid="fig2s8">Figure 2—figure supplement 8</xref>). These observations suggest that <italic>ORF3d</italic> is actively translated. Similar conclusions can be drawn for <italic>ORF3c</italic>, <italic>ORF3d-2</italic>, and <italic>ORF9b</italic>, but not <italic>ORF9c</italic> (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s7">Figure 2—figure supplement 7</xref>, <xref ref-type="fig" rid="fig2s9">Figure 2—figure supplement 9</xref>).</p><p>Additional experiments have also provided evidence of ORF3d translation. <xref ref-type="bibr" rid="bib32">Gordon et al., 2020</xref> used overexpression experiments to demonstrate that ORF3d (referred to as ‘ORF3b’; <xref ref-type="table" rid="table1">Table 1</xref>) can be stably expressed and that it interacts with the mitochondrial protein STOML2. Most compellingly, ORF3d, ORF8, and N elicit the strongest antibody responses observed in COVID-19 patient sera, with ORF3d sufficient to accurately diagnose the majority of COVID-19 cases (<xref ref-type="bibr" rid="bib36">Hachim et al., 2020</xref>). Because <italic>ORF3d</italic> is restricted to SARS-CoV-2 and pangolin-CoV (see below), this finding is unlikely to be due to cross-reactivity with another coronavirus and provides strong independent evidence of ORF3d translation during infection.</p></sec><sec id="s2-3"><title>Protein sequence properties</title><p>To further investigate the antigenic properties of ORF3d, we predicted linear T cell epitopes for each SARS-CoV-2 protein. We employed NetMHCpan (<xref ref-type="bibr" rid="bib44">Jurtz et al., 2017</xref>) for MHC class I (cytotoxic CD8+ T cells), an approach shown to accurately predict SARS-CoV-2 epitopes shared with SARS-CoV (<xref ref-type="bibr" rid="bib34">Grifoni et al., 2020</xref>), and NetMHCIIpan (<xref ref-type="bibr" rid="bib73">Reynisson et al., 2020</xref>) for MHC class II (helper CD4+ T cells). Specifically, we tested all 9 amino acid (MHC I) or 15 amino acid (MHC II) substrings of each viral protein for predicted weak or strong binding by MHC. Epitope density was estimated as the mean number of predicted epitopes overlapping each residue for each protein. We also tested two sets of negative controls: (1) randomized peptides generated from each protein, representing the result expected given amino acid content alone and (2) short unannotated ORFs present in the SARS-CoV-2 genome, representing the result expected for ORFs that have been evolving without functional constraint.</p><p>For CD8+ T cells, the lowest predicted epitope density occurs in ORF3d (1.5 per residue), which is unexpected given its own amino acid content (p=0.150) and compared to short unannotated ORFs (p=0.078; permutation tests). The next lowest densities occur in N and ORF8 (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Intriguingly, as previously mentioned, these three peptides (ORF3d, N, and ORF8) also elicit the strongest antibody (B cell epitope) responses measured in COVID-19 patient sera (<xref ref-type="bibr" rid="bib36">Hachim et al., 2020</xref>), suggesting a possible balance between CD8+ T and B cell epitopes. For CD4+ T cells, again, ORF3d has one of the lowest predicted epitope densities (5.6 per residue; p≥0.291), with lower values seen in only three other genes. Focusing instead on the shorter ORF3d-2 isoform, this protein contains zero predicted epitopes, which is a highly significant depletion given its own amino acid content (p=0.001) and compared to short unannotated ORFs (p=0.001). These observations suggest either a predisposition toward immune escape, allowing gene survival, or the action of selective pressures on <italic>ORF3d</italic> or <italic>ORF3d-2</italic> to remove epitopes. In stark contrast to ORF3d, ORF3c has the highest predicted CD8+ T cell epitope density (8.4 per residue), apparently as a function of its amino acid content (i.e. not differing from its randomized peptides; p=0.996). The enrichment of predicted epitopes in unannotated proteins (e.g. ORF3c and randomized peptides) but not N, for which numerous epitopes are documented (<xref ref-type="bibr" rid="bib34">Grifoni et al., 2020</xref>), demonstrates that ascertainment or methodological biases cannot account for the depletion of predicted epitopes in ORF3d.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>SARS-CoV-2 protein sequence properties.</title><p>(<bold>A</bold>) Predicted densities of MHC class I-bound CD8+ T cell 9 amino acid (aa) epitopes (top) and MHC class II-bound CD4+ T cell 15 aa epitopes (bottom). Results for proteins encoded downstream of <italic>ORF1ab</italic> are shown. Mean numbers of predicted epitopes per residue (blue bars) are calculated as the number of epitopes overlapping each amino acid position divided by protein length. Error bars show 95% confidence intervals. Two sets of negative controls were also tested: (1) <italic>n</italic> = 1000 randomized peptides generated from each protein by randomly sampling its amino acids with replacement (dark gray bars), representing the result expected given amino acid content alone; and (2) short unannotated ORFs, the peptides encoded by <italic>n</italic> = 103 putatively nonfunctional ORFs present in the SARS-CoV-2 genome, representing the result expected for ORFs that have been evolving without functional constraint. For the short unannotated ORFs, the horizontal gray dotted line shows the mean number of epitopes per residue, and the gray-shaded region shows the 95% confidence interval (i.e. 2.5% to 97.5% quantiles). ORF3d, N, and ORF8 have the lowest MHC class I epitope densities; ORF3d, ORF3b, ORF7b, and ORF10 have the lowest MHC class II epitope densities. (<bold>B</bold>) Hydrophobicity profiles of amino acid sequences encoded by the three forward-strand reading frames of the <italic>ORF3a</italic>/<italic>ORF3c</italic>/<italic>ORF3d</italic> gene region, as calculated by the VOLPES server, using the unitless ‘Factor 1’ consensus hydrophobicity scale. Frame is reported using <italic>ORF3a</italic> as the reference, for example ss12 refers to the frame encoding <italic>ORF3d</italic>, for which codon position 2 overlaps codon position 1 of <italic>ORF3a</italic> (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>epitope_summary_MHCI_LONG.txt.</title><p>Source data for MHC class I in <xref ref-type="fig" rid="fig3">Figure 3A</xref>.</p></caption><media mime-subtype="plain" mimetype="text" xlink:href="elife-59633-fig3-data1-v2.txt"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>epitope_summary_MHCII_LONG.txt.</title><p>Source data for MHC class II in <xref ref-type="fig" rid="fig3">Figure 3A</xref>.</p></caption><media mime-subtype="plain" mimetype="text" xlink:href="elife-59633-fig3-data2-v2.txt"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>hydrophobicity_profiles_ORF3a_corr.txt.</title><p>Source data for hydrophobicity profiles in <xref ref-type="fig" rid="fig3">Figure 3B</xref>.</p></caption><media mime-subtype="plain" mimetype="text" xlink:href="elife-59633-fig3-data3-v2.txt"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Structural prediction for the ORF3d protein.</title><p>Independent computational modeling predictions of <italic>α</italic>-helices at the secondary (left inset, carried out in NetSurf v2) and tertiary structure levels (right inset, carried out in I-TASSER). Folding concordance with the closest protein structure match is shown (rightmost inset, aligned with TM-align). For explanation of shown metrics, see <ext-link ext-link-type="uri" xlink:href="https://zhanglab.ccmb.med.umich.edu/I-TASSER">https://zhanglab.ccmb.med.umich.edu/I-TASSER</ext-link>. <xref ref-type="bibr" rid="bib14">Chan et al., 2020</xref> also predict a fold with <italic>α</italic>-helices (Raven Kok, pers. comm.).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Correlations between hydrophobicity profiles of amino acid sequences encoded by the three forward-strand reading frames of the <italic>ORF3a</italic> region.</title><p>Vertical dotted gray lines denote gene start sites. (<bold>A</bold>) Hydrophobicity profiles of the amino acid sequences encoded by all three forward-strand reading frames of <italic>ORF3a</italic>. Details as in <xref ref-type="fig" rid="fig3">Figure 3B</xref>, except the entire region encoding <italic>ORF3a</italic> is shown. (<bold>B</bold>) Correlations (Spearman’s rank) between hydrophobicity profiles for the three forward-strand reading frames. Color denotes significance.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Correlation between hydrophobicity profiles in the amino acid sequences encoded by all three forward-strand frames of <italic>ORF3a</italic>, by gene subregion.</title><p>Details as in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>. <italic>ORF3a</italic> (left) refers to those codons of <italic>ORF3a</italic> that encode residues not overlapping any hypothesized overlapping genes. Codons counts refer to <italic>ORF3a</italic>, that is 21 codons of <italic>ORF3a</italic> (20 codons of <italic>ORF3d</italic>) are involved in a triple overlap (at least one nucleotide) with <italic>ORF3c</italic>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig3-figsupp3-v2.tif"/></fig></fig-group><p>Our structural prediction for the ORF3d protein suggests <italic>α</italic>-helices connected with coils and an overall fold model that matches known protein structures (e.g. Protein Data Bank IDs 2WB7 and 6A93) with borderline confidence (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), similar to the predictions of <xref ref-type="bibr" rid="bib14">Chan et al., 2020</xref>. Remarkably, biochemical properties that influence the structure of this novel protein appear to be inherited from the pre-existing ORF3a protein sequence encoded by the overlapping reading frame. It has recently been shown that frame-shifted nucleotide sequences tend to encode proteins with similar hydrophobicity profiles as a consequence of the standard genetic code (<xref ref-type="bibr" rid="bib3">Bartonek et al., 2020</xref>). To explore whether this is the case for <italic>ORF3d</italic>, we used the VOLPES server (<xref ref-type="bibr" rid="bib4">Bartonek and Zagrovic, 2019</xref>) to calculate the hydrophobicity profiles (<xref ref-type="bibr" rid="bib2">Atchley et al., 2005</xref>) of the peptides encoded by all three frames of <italic>ORF3a</italic>. The maximum correlation observed occurs between the frames of <italic>ORF3a</italic> (ss11) and <italic>ORF3d</italic> (ss12) in the region encoding ORF3d (ORF3a residues 64–102), with <italic>r</italic><sub>S</sub> = 0.87 (p=5.79 × 10<sup>−13</sup>, Spearman’s rank), which is much stronger than the correlation between these frames observed for the non-OLG residues of ORF3a (<italic>r</italic><sub>S</sub> = 0.27, p=8.70 × 10<sup>−4</sup>) (<xref ref-type="fig" rid="fig3">Figure 3C</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). This conservation of a structure-related property with the ORF3a protein provides further evidence for <italic>ORF3d</italic> functionality, and may predispose this region toward de novo gene birth. Again, <italic>ORF3c</italic> shows the opposite pattern, as the minimum correlation observed between hydrophobicity profiles occurs between the frames of <italic>ORF3a</italic> (ss11) and <italic>ORF3c</italic> (ss13) in the region encoding ORF3c (ORF3a residues 22–43), with <italic>r</italic><sub>S</sub> = −0.40 (p=6.16 × 10<sup>−2</sup>). Such disparate hydrophobicity profiles may be due to the strong conservation of <italic>ORF3c</italic> (see below).</p></sec><sec id="s2-4"><title><italic>ORF3d</italic> taxonomic distribution and origins</title><p>To assess the origin of <italic>ORF3d</italic> and its conservation within and among host taxa, we aligned 21 <italic>Severe acute respiratory syndrome-related coronavirus</italic> genomes reported by <xref ref-type="bibr" rid="bib51">Lam et al., 2020</xref> (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), limiting our analysis to those with an annotated <italic>ORF1ab</italic> and no frameshift variants relative to SARS-CoV-2 in the core genes <italic>ORF1ab</italic>, <italic>S</italic>, <italic>ORF3a</italic>, <italic>E</italic>, <italic>M</italic>, <italic>ORF7a</italic>, <italic>ORF7b</italic>, and <italic>N</italic> (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>; SARS-related-CoV_ALN.fasta, supplementary data). All other genes are also intact (i.e. there are no mid-sequence STOP codons) in all genomes (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), with the exception of <italic>ORF3d</italic>, <italic>ORF3b</italic>, and <italic>ORF8</italic> (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Specifically, <italic>ORF3d</italic> is intact in only two sequences: SARS-CoV-2 Wuhan-Hu-1 and pangolin-CoVs from Guangxi (GX/P5L). Full-length <italic>ORF3b</italic> is intact in only three sequences: SARS-CoV TW11, SARS-CoV Tor2, and bat-CoV Rs7327, with the remainder having premature STOP codons (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Finally, <italic>ORF8</italic> is intact in all but five sequences, where it contains premature STOP codons or large-scale deletions (<xref ref-type="fig" rid="fig1">Figure 1B</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Amino acid variation in proteins encoded by genes overlapping <italic>ORF3a</italic> in viruses of the species <italic>Severe acute respiratory syndrome-related coronavirus</italic>.</title><p>(<bold>A</bold>) Amino acid sequences of ORF3c, ORF3d, and ORF3b, as encoded by SARS-CoV-2 (Wuhan-Hu-1; NCBI: NC_045512.2). Note that, while ORF3b encodes a protein of 154 amino acids (aa) in SARS-CoV (NCBI: NC_004718.3), a premature STOP codon in SARS-CoV-2 has resulted in an ORF encoding only 22 aa. (<bold>B</bold>) Amino acid alignments of ORF3c, ORF3d, and ORF3b (3b) show their sequence conservation. Black lines indicate STOP codons in <italic>ORF3d</italic> and <italic>ORF3b</italic>, showing their restricted taxonomic ranges. Intact <italic>ORF3d</italic> is restricted to SARS-CoV-2 and pangolin-CoV GX/P5L; however, note that ORF3d-2 (denoted 3d-2), a shorter isoform of ORF3d, could have a slightly wider taxonomic range if TTG or GTG are permitted as translation initiation codons. Full-length ORF3b (ORF3b region) is found throughout members of this virus species, but truncated early in most genomes outside of SARS-CoV (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), with the shortest isoform (denoted 3b) found in SARS-CoV-2 and closely related viruses.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>aa_alignments_3c_3d_3b.xlsx.</title><p>Amino acid alignments shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>. The full translation of the <italic>ORF3b</italic> region is provided for ORF3b. Note that the pangolin-CoV GD/1 sequence has been masked as X (license constraint), but can be acquired with GISAID registration.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59633-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig4-v2.tif"/></fig><p>The presence of intact <italic>ORF3d</italic> homologs among viruses infecting different host species (human and pangolin) raises the possibility of functional conservation. However, the taxonomic distribution of this ORF is incongruent with whole-genome phylogenies in that <italic>ORF3d</italic> is intact in the pangolin-CoV more distantly related to SARS-CoV-2 (GX/P5L) but not the more closely related one (GD/1) (<xref ref-type="fig" rid="fig4">Figure 4</xref>), a finding confirmed by the alignment of <xref ref-type="bibr" rid="bib9">Boni et al., 2020</xref>. New sequence data reveal similarly puzzling trends: <italic>ORF3d</italic> contains STOP codons in the closely related bat-CoV RmYN02 (GISAID: EPI_ISL_412977; data not shown), but it is intact in three more distantly related bat-CoVs discovered in Rwanda and Uganda, where it is further extended by 20 codons (total 78 codons) but shows no evidence of conservation with SARS-CoV-2 (<xref ref-type="bibr" rid="bib86">Wells et al., 2020</xref> and pers. comm; data not shown). Further, phylogenies of the 21 <italic>Severe acute respiratory syndrome-related coronavirus</italic> genomes built on <italic>ORF3a</italic> are incongruent with whole-genome phylogenies, likely due to the presence of recombination breakpoints in <italic>ORF3a</italic> near <italic>ORF3d</italic> (<xref ref-type="bibr" rid="bib9">Boni et al., 2020</xref>; <xref ref-type="bibr" rid="bib72">Rehman et al., 2020</xref>). Recombination, convergence, or recurrent loss may therefore have played a role in the origin and taxonomic distribution of <italic>ORF3d</italic>.</p></sec><sec id="s2-5"><title>Between-taxa divergence</title><p>To estimate natural selection on <italic>ORF3d</italic>, we measured viral diversity at three hierarchical evolutionary levels: between-taxa, between-host, and within-host. Specifically, between-taxa refers to divergence (<italic>d</italic>) among the 21 aforementioned viruses infecting bat, human, or pangolin (<xref ref-type="fig" rid="fig1">Figure 1B</xref>); between-host refers to diversity (<italic>π</italic>) between consensus-level SARS-CoV-2 genomes infecting different human individuals; and within-host refers to <italic>π</italic> in deeply sequenced ‘intrahost’ SARS-CoV-2 samples from single human individuals. At each level, we inferred selection by estimating mean pairwise nonsynonymous (<italic>d</italic><sub>N</sub> or <italic>π</italic><sub>N</sub>; amino acid changing) and synonymous (<italic>d</italic><sub>S</sub> or <italic>π</italic><sub>S</sub>; not amino acid changing) distances among all sequences. Importantly, we combined standard (non-OLG) methods (<xref ref-type="bibr" rid="bib61">Nei and Gojobori, 1986</xref>; <xref ref-type="bibr" rid="bib63">Nelson et al., 2015</xref>) with OLGenie, a new <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> method tailored for OLGs (hereafter OLG <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub>), which we previously used to verify purifying selection on a novel OLG in HIV-1 (<xref ref-type="bibr" rid="bib64">Nelson et al., 2020a</xref>).</p><p>The only gene to show significant evidence of purifying selection at all three evolutionary levels is the nucleocapsid gene <italic>N</italic> (<xref ref-type="fig" rid="fig5">Figure 5</xref>), which undergoes disproportionately low rates of nonsynonymous change (<italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> &lt; 1 and <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub> &lt; 1) specifically in its non-OLG regions, evidencing strict functional constraint. <italic>N</italic> is also the most highly expressed gene (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>), confirming that selection has more opportunity to act when a protein is manufactured in abundance (<xref ref-type="fig" rid="fig2">Figure 2B</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) (Materials and methods). Importantly, this signal can be missed if non-OLG methods are applied to <italic>N</italic> without accounting for its internal OLGs, <italic>ORF9b</italic> and <italic>ORF9c</italic> (e.g. at the between-host level, p=0.0268 when excluding OLG regions, but p=0.411 when including them; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Natural selection analysis of viral nucleotide differences at three hierarchical evolutionary levels.</title><p>Nucleotide differences in each virus gene were analyzed at three host levels: between-taxa divergence (<italic>d</italic>) among <italic>Severe acute respiratory syndrome-related coronavirus</italic> genomes infecting bat, human, and pangolin species; between-host diversity (<italic>π</italic>) for SARS-CoV-2 infecting human individuals (consensus-level); and within-host diversity (<italic>π</italic>) for SARS-CoV-2 infecting human individuals (deep sequencing). Each gene/level is shaded according to the ratio of mean nonsynonymous to synonymous differences per site to indicate purifying selection (<italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> &lt; 1 or <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub> &lt; 1; blue) or positive selection (<italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> &gt; 1 or <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub> &gt; 1; red). The extremely low ratio for <italic>ORF3c</italic> was artificially adjusted to allow the display of other ratios, and a Jukes-Cantor correction was applied to <italic>d</italic><sub>N</sub> and <italic>d</italic><sub>S</sub> values. Values range from a minimum of <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S </sub>= 0.04 (<italic>ORF3c</italic>, between-host; p=0.0410) to a maximum of 21.0 (<italic>ORF9c</italic>, between-host; p=0.126), where significance was evaluated using <italic>Z</italic>-tests of the hypothesis that <italic>d</italic><sub>N</sub>-<italic>d</italic><sub>S</sub> = 0 or <italic>π</italic><sub>N</sub>-<italic>π</italic><sub>S</sub> = 0 (10,000 bootstrap replicates, codon unit). The mean of all pairwise comparisons is shown for sequenced genomes only, i.e. no ancestral sequences were reconstructed or inferred. For each gene, sequences were only included in the between-species analysis if a complete, intact ORF (no STOPs) was present. Genes containing an overlapping gene (OLG) in a different frame were analyzed separately for non-OLG and OLG regions using SNPGenie and OLGenie, respectively. For <italic>ORF3b</italic>, only the region corresponding to the first ORF in SARS-CoV-2 (<xref ref-type="table" rid="table1">Table 1</xref>) was analyzed. The short overlap between <italic>ORF1a</italic> and <italic>ORF1b</italic> (<italic>nsp11</italic> and <italic>nsp12</italic>) was excluded from the analysis. Error bars represent the standard error of mean pairwise differences. See Materials and methods for further details.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>selection_three_levels.txt.</title><p>Source data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</p></caption><media mime-subtype="plain" mimetype="text" xlink:href="elife-59633-fig5-data1-v2.txt"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>SARS-CoV-2 between-host nucleotide diversity and allele frequencies as a function of date during the initial period of the COVID-19 pandemic.</title><p>Analyses refer to human SARS-CoV-2 consensus sequences obtained from GISAID. Results show sliding windows of 14 days (step size = 7 days) representing 13 time points since the first GISAID sample was collected (EPI_ISL_402123 on 12/24/2019). Regions with overlapping genes were excluded from estimates of <italic>π</italic>. Shaded regions show standard error of mean <italic>π</italic><sub>N</sub>, <italic>π</italic><sub>S</sub>, or <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub> (10,000 bootstrap replicates, codon unit). (<bold>A</bold>) Nonsynonymous (<italic>π</italic><sub>N</sub>) and synonymous (<italic>π</italic><sub>S</sub>) nucleotide diversity. (<bold>B</bold>) <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub>, where the horizontal dashed gray line denotes the <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub> ratio expected under neutrality (1.0). (<bold>C</bold>) Diversity of sampling locations measured as entropy, defined as -∑<italic>p</italic>*ln(<italic>p</italic>), where <italic>p</italic> is the number of distinct (unique) locations or countries reported for a given window (<xref ref-type="bibr" rid="bib23">Ewens and Grant, 2001</xref>). (<bold>D</bold>) Allele frequency trajectories of the <italic>ORFd</italic>-LOF mutation, colored by continent and limited to sufficient sample sizes (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Correlation between natural selection and gene expression.</title><p>A weak negative Spearman correlation between <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S </sub>(<italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub>) and gene expression is observed across all three evolutionary levels (between-taxa, between-host, and within-host). The x-axes of different panels differ by method for inferring gene expression, which are those shown in <xref ref-type="fig" rid="fig2">Figure 2B</xref>: (1) ‘Mass spec’ refers to log<sub>10</sub>(iBAQ prop), where iBAQ prop is the proportion of the maximum intensity-based absolute quantification (iBAQ) observed; (2) ‘Upstream peak’ is the peak in ribosome profiling read depth upstream of the gene start site, measured for reads of length 29-31nt (<xref ref-type="fig" rid="fig2">Figure 2A</xref>); and (3) ‘In-frame mean’ is the mean read depth at Codon pos 1, measured for reads of length 30nt (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). A given gene (color) has only one selection value (y-axis) per evolutionary level, and only one gene expression value (x-axis) per method for determining expression. Selection was calculated as <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> (<italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub>) except for the overlapping gene <italic>ORF9b</italic>, where the OLG-appropriate measure <italic>d</italic><sub>NN</sub>/<italic>d</italic><sub>NS</sub> (<italic>π</italic><sub>NN</sub>/<italic>π</italic><sub>NS</sub>) was used (see Materials and methods).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig5-figsupp2-v2.tif"/></fig></fig-group><p>With respect to <italic>ORF3d</italic>, comparison of Wuhan-Hu-1 to pangolin-CoV GX/P5L (NCBI: MT040335.1) yields OLG <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> = 0.14 (p=0.264) (<xref ref-type="fig" rid="fig5">Figure 5</xref>), whereas inclusion of a third allele found in pangolin-CoV GX/P4L (NCBI: MT040333.1) yields 0.43 (p=0.488) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Because this is suggestive of constraint, we performed sliding windows of OLG <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> across the length of <italic>ORF3a</italic>. Pairwise comparisons of each sequence to SARS-CoV-2 reveal OLG <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> &lt; 1 that is specific to the reading frame, genome positions, and species in which <italic>ORF3d</italic> is intact (pangolin-CoV GX/P5L) (<xref ref-type="fig" rid="fig6">Figure 6</xref>, left). This signal is independent of whether STOP codons are present, so its consilience with the only intact ORF in this region and species is highly suggestive of purifying selection. We note that this conclusion does not contradict studies which fail to find evidence of <italic>ORF3d</italic> conservation when comparing taxa where <italic>ORF3d</italic> is absent (e.g. <xref ref-type="bibr" rid="bib43">Jungreis et al., 2020</xref>), because <italic>ORF3d</italic> is a novel gene and would by definition lack such conservation. This contrastive signal is also similar to what is observed for the known OLGs <italic>ORF3b</italic> (in comparisons to SARS-CoV; <xref ref-type="fig" rid="fig6">Figure 6</xref>, right), and <italic>ORF9b</italic> and <italic>ORF9c</italic> (in both viruses; <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Between-taxa sliding window analysis of natural selection on overlapping frames of <italic>ORF3a</italic>.</title><p>Pairwise sliding window analysis (window size = 50 codons; step size = 1 codon) of selection across members of the species <italic>Severe acute respiratory syndrome-related coronavirus</italic>. OLG-appropriate <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> values were computed using OLGenie (<xref ref-type="bibr" rid="bib64">Nelson et al., 2020a</xref>), a method that is conservative (non-conservative) for detecting purifying (positive) selection, and a Jukes-Cantor correction for multiple hits was employed. On the left-hand side, each genome is compared to SARS-CoV-2 in the ss12 reading frame of <italic>ORF3a</italic>, which contains <italic>ORF3d</italic> (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig2">Figure 2C</xref>). This frame shows evidence for purifying selection specific to the <italic>ORF3d</italic> region that is limited to the comparison with pangolin-CoV GX/P5L. On the right-hand side, this analysis is repeated for the ss13 reading frame of <italic>ORF3a</italic>, which contains <italic>ORF3c</italic> and <italic>ORF3b</italic> (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig2">Figure 2C</xref>), this time with respect to SARS-CoV, where full-length <italic>ORF3b</italic> is functional. This frame shows constraint across much of this gene and virus species, and <italic>ORF3c</italic> in particular is deeply conserved.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>SARS-CoV-2-ref_ORF3a_ss12_windows.txt.</title><p>OLGenie sliding window <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> results for comparisons to SARS-CoV-2 in the frame of <italic>ORF3d</italic>, shown on the left side of <xref ref-type="fig" rid="fig6">Figure 6</xref>.</p></caption><media mime-subtype="plain" mimetype="text" xlink:href="elife-59633-fig6-data1-v2.txt"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>SARS-CoV-ref_ORF3a_ss13_windows.txt.</title><p>OLGenie sliding window <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> results for comparisons to SARS-CoV in the frame of <italic>ORF3b</italic>, shown on the right side of <xref ref-type="fig" rid="fig6">Figure 6</xref>.</p></caption><media mime-subtype="plain" mimetype="text" xlink:href="elife-59633-fig6-data2-v2.txt"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Between-taxa sliding window of genes overlapping <italic>N</italic>.</title><p>Pairwise OLGenie analysis of the <italic>N</italic> gene’s ss13 reading frame across members of the species <italic>Severe acute respiratory syndrome-related coronavirus</italic>. Details as in <xref ref-type="fig" rid="fig6">Figure 6</xref>, except only the ss13 frame is shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig6-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Between-host evolution and pandemic spread</title><p>Purifying selection can be specific to just one taxon, as in the case of novel genes. Thus, to measure selection within SARS-CoV-2 only, we obtained 3978 high-quality human SARS-CoV-2 consensus sequences from GISAID (accessed April 10, 2020; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>; <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Between-host diversity was sufficient to detect marginally significant purifying selection across all genes (<italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S </sub>= 0.50, p=0.0613, <italic>Z</italic>-test; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>) but not most individual genes (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Therefore, we instead investigated single mutations over time, limiting to 27 high-frequency variants (minor allele frequency ≥2%; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><p>One high-frequency mutation occurred in <italic>ORF3d</italic>: G25563U, here denoted <italic>ORF3d</italic>-LOF (<italic>ORF3d</italic>-loss-of-function). This mutation causes a STOP codon in <italic>ORF3d</italic> (ORF3d-E14*) but nonsynonymous changes in both <italic>ORF3a</italic> (ORF3a-Q57H) and <italic>ORF3c</italic> (ORF3c-R36I), another OLG that overlaps this site (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). <italic>ORF3d</italic>-LOF is not observed in any other species member included in our analysis (<xref ref-type="fig" rid="fig4">Figure 4</xref>; SARS-related-CoV_ALN.fasta, supplementary data). During the first months of the COVID-19 pandemic, <italic>ORF3d</italic>-LOF increased in frequency (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) in multiple locations (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), making this mutation a candidate for natural selection on ORF3a, ORF3c, ORF3d, or any combination thereof (<xref ref-type="bibr" rid="bib50">Kosakovsky-Pond, 2020</xref>). However, temporal allele frequency trajectories (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>) and similar signals from phylogenetic branch tests may also be caused by founder effects or genetic drift, and are susceptible to ascertainment bias (e.g. preferential sequencing of imported infections and uneven geographic sampling) and stochastic error (e.g. small sample sizes).</p><p>To partially account for these confounding factors, we instead constructed the mutational path leading from the SARS-CoV-2 haplotype collected in December 2019 to the haplotype carrying <italic>ORF3d</italic>-LOF. This path involves five mutations (C241U, C3037U, C14408U, A23403G, G25563U), constituting five observed haplotypes (EP–3 → EP–2 → EP → EP+1 → EP+1+LOF), shown in <xref ref-type="table" rid="table2">Table 2</xref>. Here, EP is suggested to have driven the European Pandemic (detected in German patient #4; see footnote 3 of <xref ref-type="table" rid="table2">Table 2</xref>; <xref ref-type="bibr" rid="bib49">Korber et al., 2020</xref>; <xref ref-type="bibr" rid="bib74">Rothe et al., 2020</xref>); EP–3 is the Wuhan founder haplotype; EP–1 is never observed in our dataset; and LOF refers to <italic>ORF3d</italic>-LOF. We then documented the frequencies and earliest collection date of each haplotype (<xref ref-type="table" rid="table2">Table 2</xref>) to determine when <italic>ORF3d</italic>-LOF occurred on the EP background.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>The mutational path to European pandemic founder haplotypes<sup>*</sup>.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Variant</th><th valign="bottom">EP–3</th><th valign="bottom">EP–2</th><th valign="bottom">EP<sup>†</sup></th><th valign="bottom">EP+1<sup>†</sup></th><th valign="bottom">EP+1+LOF</th></tr></thead><tbody><tr><td valign="bottom">C241U (5′-UTR)</td><td valign="bottom">-</td><td valign="bottom">-</td><td valign="bottom">+</td><td valign="bottom">+</td><td valign="bottom">+</td></tr><tr><td valign="bottom">C3037U (nsp3-F106F)</td><td valign="bottom">-</td><td valign="bottom">-</td><td valign="bottom">+</td><td valign="bottom">+</td><td valign="bottom">+</td></tr><tr><td valign="bottom">C14408U (RdRp-P323L)</td><td valign="bottom">-</td><td valign="bottom">-</td><td valign="bottom">-</td><td valign="bottom">+</td><td valign="bottom">+</td></tr><tr><td valign="bottom">A23403G (Spike-D614G)</td><td valign="bottom">-</td><td valign="bottom">+</td><td valign="bottom">+</td><td valign="bottom">+</td><td valign="bottom">+</td></tr><tr><td valign="bottom">G25563U (ORF3a-Q57H/ORF3c-R36I/ORF3d-E14*)</td><td valign="bottom">-</td><td valign="bottom">-</td><td valign="bottom">-</td><td valign="bottom">-</td><td valign="bottom">+</td></tr><tr><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="bottom">Earliest collection<sup>§</sup></td><td valign="bottom">24-Dec</td><td valign="bottom">7-Feb</td><td valign="bottom">28-Jan</td><td valign="bottom">20-Feb</td><td valign="bottom">21-Feb</td></tr><tr><td valign="bottom">Earliest location<sup>§</sup></td><td valign="bottom">Wuhan</td><td valign="bottom">Wuhan</td><td valign="bottom">Munich (Shanghai)<sup>‡</sup></td><td valign="bottom">Lombardy</td><td valign="bottom">Hauts de France</td></tr><tr><td valign="bottom">Occurrence in China</td><td valign="bottom">233</td><td valign="bottom">1</td><td valign="bottom">1 (2)<sup>‡</sup></td><td valign="bottom">0</td><td valign="bottom">0</td></tr><tr><td valign="bottom">Occurrence in Europe</td><td valign="bottom">458</td><td valign="bottom">0</td><td valign="bottom">21</td><td valign="bottom">1153</td><td valign="bottom">310</td></tr><tr><td valign="bottom">Occurrence in Italy</td><td valign="bottom">1</td><td valign="bottom">0</td><td valign="bottom">0</td><td valign="bottom">27</td><td valign="bottom">0</td></tr><tr><td valign="bottom">Occurrence in Germany</td><td valign="bottom">15</td><td valign="bottom">0</td><td valign="bottom">1</td><td valign="bottom">11</td><td valign="bottom">21</td></tr><tr><td valign="bottom">Occurrence in Belgium</td><td valign="bottom">27</td><td valign="bottom">1</td><td valign="bottom">20</td><td valign="bottom">187</td><td valign="bottom">27</td></tr><tr><td valign="bottom">Occurrence in UK</td><td valign="bottom">210</td><td valign="bottom">0</td><td valign="bottom">0</td><td valign="bottom">338</td><td valign="bottom">38</td></tr><tr><td valign="bottom">Occurrence in Iceland</td><td valign="bottom">56</td><td valign="bottom">0</td><td valign="bottom">0</td><td valign="bottom">212</td><td valign="bottom">54</td></tr><tr><td valign="bottom">Occurrence in France</td><td valign="bottom">14</td><td valign="bottom"/><td valign="bottom">0</td><td valign="bottom">72</td><td valign="bottom">102</td></tr><tr><td valign="bottom">Occurrence in US</td><td valign="bottom">467</td><td valign="bottom">0</td><td valign="bottom">0</td><td valign="bottom">88<sup>**</sup></td><td valign="bottom">326<sup>**</sup></td></tr><tr><td valign="bottom">Total in GISAID<sup>††</sup></td><td valign="bottom">1610</td><td valign="bottom">2</td><td valign="bottom">22</td><td valign="bottom">1455</td><td valign="bottom">752</td></tr></tbody></table><table-wrap-foot><fn><p><sup>*</sup>Haplotypes are here defined by the presence (+) or absence (-) of five high-frequency variants (rows 1–5), and other variants with lower frequencies on these backgrounds are ignored. EP-1 is not observed in our dataset.</p><p><sup>†</sup>The EP haplotype is first detected in German patient #4 and is a documented founder for coronavirus spread in Germany (<xref ref-type="bibr" rid="bib74">Rothe et al., 2020</xref>). Neither the EP nor EP+1 haplotypes were detectable between January 28 and February 20, although they immediately became a major haplotype once EP+1 was detectable. Failure to detect these two haplotypes during these 3 weeks could potentially be explained by ascertainment bias, for example lack of testing for travel-independent cases.</p></fn><fn><p><sup>‡</sup>This Shanghai sample (GISAID: EPI_ISL_416327) comprises 1.32% poly-Ns and failed our quality control criteria, but is added here since it is potentially relevant to the origin of the EP haplotype. Including this sample, the EP haplotype is observed in Shanghai twice.</p><p><sup>§</sup>The earliest collection location and time are highly subject to collection and submission bias and do not necessarily reflect where the mutation/haplotype first occurred.</p></fn><fn><p><sup>**</sup>There is likely a testing bias in the United States, as the EP+1+LOF haplotype was often detected in Washington but EP+1 was not.</p><p><sup>††</sup>These numbers are based on 3853 samples from December 24 to April 1 at the time of GISAID accession that passed both our quality control criteria for alignment and for this particular analysis (i.e. no ambiguous genotype calls among the five SNPs in this table), unless otherwise stated.</p></fn></table-wrap-foot></table-wrap><p>Surprisingly, despite its expected predominance in Europe due to a founder effect, the EP haplotype is extremely rare. By contrast, haplotypes with one additional mutation (C14408U; RdRp-P323L) on the EP background are common in Europe, and <italic>ORF3d</italic>-LOF occurred very early on this background to create EP+1+LOF from EP+1. Neither of these two haplotypes was initially observed in China (<xref ref-type="table" rid="table2">Table 2</xref>), suggesting that they might have arisen in Europe. Thus, we further partitioned the samples into two groups, corresponding to countries with early founders (January samples) or only late founders (no January samples) (<xref ref-type="fig" rid="fig7">Figure 7</xref>). In the early founder group, EP–3 (Wuhan) is the first haplotype detected in most countries, consistent with most early COVID-19 cases being related to travel from Wuhan. Because this implies that genotypes EP–3 and EP had longer to spread in the early founder group, it is surprising that their spread is dwarfed by an increase in EP+1 and EP+1+LOF starting in late February. This turnover is most evident in the late founder group, where multiple haplotypes are detected in a narrow time window, and the number of cumulative samples is always dominated by EP+1 and EP+1+LOF. Thus, while founder effects and drift are plausible explanations, it is also worth investigating whether the early spread of <italic>ORF3d</italic>-LOF may have been caused by its linkage with another driver, either C14408U (+1 variant) or a subsequent variant(s) occurring on the EP+1+LOF background (Discussion).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Pandemic spread of the EP+1 haplotype and the hitchhiking of <italic>ORF3d</italic>-LOF.</title><p>The mutational path leading to EP+1+LOF is shown in the upper panel. Cumulative frequencies of haplotypes in samples from Germany and five other countries with the most abundant sequence data are shown in the lower panel. Countries are grouped into early founder (left) and late founder (right) based on the presence or absence of SARS-CoV-2 samples from January, respectively. In the early founder group, EP–3 (gray) is observed earlier than other haplotypes in France and the US, and EP (red) is observed early in Germany, giving them the advantage of a founder effect. However, neither EP nor EP–3 dominate later spread; instead, EP+1 (yellow) and EP+1+LOF (blue) increase much faster despite their later appearance in these countries. In the late founder group, multiple haplotypes appear at approximately the same time, but EP–3 and EP spread more slowly. The green dashed line shows the combined frequencies of EP+1 and EP+1+LOF (yellow and blue, respectively). Note that EP–1 is never observed in our dataset.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig7-v2.tif"/></fig></sec><sec id="s2-7"><title>Within-host diversity and mutational bias</title><p>Examination of within-host variation across multiple samples allows detection of recurrent mutations, which might indicate mutation bias or within-host selection. To investigate these possibilities, we obtained 401 high-depth ‘intrahost’ human SARS-CoV-2 samples from the Sequence Read Archive (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) and called SNPs relative to the Wuhan-Hu-1 reference genome. Within human hosts, 42% of SNPs passed our false-discovery rate criterion (Materials and methods), with a median passing minor allele frequency of 2% (21 of 1344 reads). Using these variants to estimate within-host diversity, <italic>ORF3d</italic> does not show significant evidence of selection, with OLG <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S </sub>= 1.5 (p=0.584) (<xref ref-type="fig" rid="fig5">Figure 5</xref>). We also examined six high-depth samples of pangolin-CoVs from Guangxi, but no conclusions could be drawn due to low sequence quality (Materials and methods; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><p>To identify recurrent mutations in multiple SARS-CoV-2 samples, separately for each site, we limited to samples for which the major or fixed allele is also ancestral (i.e. matches Wuhan-Hu-1). At such sites, precluding sequencing artifacts or coinfection by multiple genotypes, minor alleles occurring in more than one sample are expected to be derived and recurrent (i.e. identical by state but not descent). For <italic>ORF3d</italic>, we observe <italic>ORF3d</italic>-LOF as a minor allele in three (0.94%) of 320 samples (frequencies of 20.7%, 6.0%, and 2.2% in samples SRR11410536, SRR11479046, and SRR11494643, respectively). This proportion of samples with a recurrent mutation is high but not unusual, as 1.7% of observed minor variants have an equal or higher proportion of recurrence. Additionally, no mutations in <italic>ORF3d</italic> recur in &gt;2.5% of samples (<xref ref-type="fig" rid="fig8">Figure 8</xref>). Thus, we find no evidence that within-host selection or mutation pressure are involved in the spread of <italic>ORF3d</italic>-LOF. However, a small number of other loci exhibit high rates of recurrent mutation, with five mutations independently observed in ~10% of samples or more (Materials and methods; <xref ref-type="fig" rid="fig8">Figure 8</xref>). Surprisingly, another STOP mutation (A404U; NSP1-L47*) is never a major allele but is observed at low frequencies in 44% of samples (<xref ref-type="fig" rid="fig8">Figure 8</xref>, <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>), unexplainable by mutational bias and warranting investigation.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>High-frequency within-host mutations.</title><p>For each site, mutations that occur in more than 2.5% of samples are shown, limiting to samples where the major or fixed allele matches Wuhan-Hu-1 at that site. The y-axis shows the proportion of such samples having the indicated minor (derived) allele. Each locus has up to three possible single-nucleotide derived alleles compared to the reference background. Open circles (black outlines) show the proportion of samples having any of the three possible derived alleles ('All'), while solid circles (color fill) show the proportion of samples having a specific derived allele (equivalent to 'All' if only one variant is observed). For most sites, only one derived mutation type (e.g. C→U) is observed across all samples. Precluding co-infection by multiple genotypes and sequencing errors, derived mutations occurring in more than one sample (y-axis) must be identical by state but not descent (i.e. recurrent). Genome positions are plotted on the x-axis, with distinct genes shown in different colors and overlapping genes shown as black blocks within reference genes. Nonsynonymous and nonsense mutations (together denoted 'Nonsyn') are indicated with a red dot. Source data are available in the supplementary material.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Recurrent nonsynonymous mutations observed in multiple human hosts.</title><p>Histogram of the derived allele frequency (DAF) of the four most common recurrent protein-coding mutations across all within-host samples (bin width = 0.01). Mutation A404U introduces a premature STOP codon in <italic>nsp1</italic>, whereas the remainder are nonsynonymous.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59633-fig8-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our analyses provide strong evidence that SARS-CoV-2 contains a novel overlapping gene (OLG), <italic>ORF3d</italic>, that has not been consistently identified or fully analyzed before this study. The annotation of a newly emerged virus is difficult, particularly in genome regions subject to frequent gene gain and loss. Moreover, due to the inherent difficulty of studying OLGs, they tend to be less carefully documented than non-OLGs; for example, <italic>ORF9b</italic> and <italic>ORF9c</italic> are still not annotated in the most-used reference genome, Wuhan-Hu-1 (last accessed September 26, 2020). Therefore, de novo and homology-based annotation are both essential, followed by careful expression analyses using multi-omic data and evolutionary analyses within and between species. In particular, we emphasize the importance of using whole-gene or genome alignments when inferring homology for both OLGs and non-OLGs, taking into account genome positions and all reading frames. Unfortunately, in the case of SARS-CoV-2, the lack of such inspections has led to mis-annotation and a domino effect. For example, homology between <italic>ORF3b</italic> (SARS-CoV) and <italic>ORF3d</italic> (SARS-CoV-2) has erroneously been implied, leading to unwarranted inferences of shared functionality (<xref ref-type="table" rid="table1">Table 1</xref>). Given the rapid growth of the SARS-CoV-2 literature, it is likely this mistake will be further propagated. We therefore provide a detailed annotation of Wuhan-Hu-1 protein-coding genes and codons in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, as a resource for future studies.</p><p>Our study highlights the highly dynamic process of frequent losses and gains of accessory genes in the species <italic>Severe acute respiratory syndrome-related coronavirus</italic>, with the greatest functional constraint typically observed for the most highly expressed genes (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). With respect to gene loss, while many accessory genes may be dispensable for viruses in cell culture, they often play an important role in natural hosts (<xref ref-type="bibr" rid="bib27">Forni et al., 2017</xref>). Thus, their loss may represent a key step in adaptation to new hosts after crossing a species barrier (<xref ref-type="bibr" rid="bib31">Gorbalenya et al., 2006</xref>). For example, the absence of full-length <italic>ORF3b</italic> in SARS-CoV-2 has received attention from only a few authors (e.g. <xref ref-type="bibr" rid="bib56">Lokugamage et al., 2020</xref>), even though it plays a central role in SARS-CoV infection and early immune interactions as an interferon antagonist (<xref ref-type="bibr" rid="bib48">Kopecky-Bromberg et al., 2007</xref>), with effects modulated by ORF length (<xref ref-type="bibr" rid="bib95">Zhou et al., 2012</xref>). Thus, the absence or truncation of <italic>ORF3b</italic> in SARS-CoV-2 may be immunologically important (<xref ref-type="bibr" rid="bib92">Yuen et al., 2020</xref>), for example in the suppression of type I interferon induction (<xref ref-type="bibr" rid="bib47">Konno et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Lokugamage et al., 2020</xref>). Further, loss of function (LOF) mutations in <italic>ORF3d</italic> and any other ORFs need to be taken into account for testing or therapeutics, particularly in light of predicted cellular interactions (<xref ref-type="bibr" rid="bib32">Gordon et al., 2020</xref>). </p><p>With respect to gene gain, the apparent presence of <italic>ORF3d</italic> coincident with the inferred entry of SARS-CoV-2 into humans from a hitherto undetermined reservoir host suggests that this gene is functionally relevant for the emergent properties of SARS-CoV-2, analogous to <italic>asp</italic> for HIV-1-M (<xref ref-type="bibr" rid="bib13">Cassan et al., 2016</xref>). The mechanisms and detailed histories of gene birth, neo-functionalization, and survival of novel genes remain unclear. However, our findings that ORF3d remarkably inherited its hydrophobicity profile from the overlapping region of ORF3a, that ORF3d is depleted for predicted CD8+ and CD4+ T cell epitopes, and that <italic>ORF3d</italic> exhibits potential purifying selection between SARS-CoV-2 and pangolin-CoV GX/P5L, provide strong leads for further research. Indeed, both the structural and immunogenic properties of new viral proteins deserve further attention and are important parts of their evolutionary story.</p><p>Failure to account for OLGs can lead to erroneous inference of (or failure to detect) natural selection in known genes, and vice versa. For example, a synonymous variant in one reading frame is very likely to be nonsynonymous in a second overlapping frame. As a result, purifying selection in the second frame usually lowers <italic>d</italic><sub>S</sub> (raises <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub>) in the first frame, increasing the likelihood of mis-inferring positive selection (<xref ref-type="bibr" rid="bib38">Holmes et al., 2006</xref>; <xref ref-type="bibr" rid="bib75">Sabath et al., 2008</xref>; <xref ref-type="bibr" rid="bib64">Nelson et al., 2020a</xref>). Such errors could, in turn, lead to mischaracterization of the genetic contributions of OLG loci to important viral properties such as incidence and persistence. One potential consequence is misguided countermeasure efforts, for example through failure to detect functionally conserved or immunologically important genome regions.</p><p>Although our study focuses on <italic>ORF3d</italic>, other OLGs have been proposed in SARS-CoV-2 and warrant investigation. <italic>ORF3d-2</italic>, a shorter isoform of <italic>ORF3d</italic> (<xref ref-type="table" rid="table1">Table 1</xref>), shows evidence of higher overall expression than <italic>ORF3d</italic> (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). However, analysis of full-length <italic>ORF3d</italic> is confounded by its 20 codon triple overlap with both <italic>ORF3a</italic> and <italic>ORF3c</italic>, making expression and selection results difficult to compare between the two isoforms. Although not evolutionarily novel, the recently discovered <italic>ORF3c</italic> (<xref ref-type="table" rid="table1">Table 1</xref>) shows deep conservation among viruses of this species (<xref ref-type="bibr" rid="bib11">Cagliani et al., 2020</xref>; <xref ref-type="bibr" rid="bib25">Firth, 2020</xref>; <xref ref-type="bibr" rid="bib43">Jungreis et al., 2020</xref>), the lowest <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub> ratio observed in our between-host analysis (<xref ref-type="fig" rid="fig5">Figure 5</xref>), strong evidence for translation in SARS-CoV-2 (<xref ref-type="fig" rid="fig2">Figure 2</xref>), and the highest predicted CD8+ T cell epitope density (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Within <italic>S</italic>, <italic>S-iORF2</italic> (genome positions 21768–21863) also shows evidence of translation from ribosome profiling (<xref ref-type="bibr" rid="bib24">Finkel et al., 2020</xref>), and between-host comparisons suggest purifying selection (<italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S </sub>= 0.22, p=0.0278) (<xref ref-type="table" rid="table1">Table 1</xref>). We therefore suggest that the SARS-CoV-2 genome could contain additional undocumented or novel OLGs.</p><p>Our comprehensive evolutionary analysis of the SARS-CoV-2 genome demonstrates that many genes are under relaxed purifying selection, consistent with the exponential growth of the virus (<xref ref-type="bibr" rid="bib29">Gazave et al., 2013</xref>). At the between-host level, nucleotide diversity increases somewhat over the initial period of the COVID-19 pandemic, tracking the number of locations sampled, while the <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub> ratio remains relatively constant at 0.46 (±0.030 SEM) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). Other genes differ in the strength and direction of selection at the three evolutionary levels, for example <italic>ORF9c</italic> (<xref ref-type="fig" rid="fig5">Figure 5</xref>), suggesting a shift in function or importance over time or between different host species or individuals. <italic>ORF3d</italic> and <italic>ORF8</italic> are among the youngest genes in SARS-CoV-2, being taxonomically restricted to a subset of betacoronaviruses (<xref ref-type="bibr" rid="bib18">Cui et al., 2019</xref>), and both exhibit high rates of change and turnover (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="fig" rid="fig5">Figure 5</xref>; SARS-related-CoV_ALN.fasta, supplementary data). High between-host <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub> was also observed in <italic>ORF8</italic> of SARS-CoV, perhaps due to a relaxation of purifying selection upon entry into civet cats or humans (<xref ref-type="bibr" rid="bib27">Forni et al., 2017</xref>). However, <italic>ORF3d</italic> and <italic>ORF8</italic> both exhibit strong antibody (B cell epitope) responses (<xref ref-type="bibr" rid="bib36">Hachim et al., 2020</xref>) and predicted T cell epitope depletion (<xref ref-type="fig" rid="fig3">Figure 3</xref>) in SARS-CoV-2. This highlights the important connection between evolutionary and immunologic processes (<xref ref-type="bibr" rid="bib19">Daugherty and Malik, 2012</xref>), as antigenic peptides may impose a fitness cost for the virus by allowing immune detection. Thus, the loss or truncation of these genes may share an immunological basis and deserves further attention.</p><p>The quick expansion of <italic>ORF3d</italic>-LOF (EP+1+LOF) and its background (EP+1) during this pandemic is surprising, given that a founder effect would have favored other variants that arrived earlier. However, newer data show that <italic>ORF3d</italic>-LOF has remained at relatively low frequencies compared to EP+1 variants (<xref ref-type="bibr" rid="bib50">Kosakovsky-Pond, 2020</xref>), and plausible explanations exist which do not require invoking natural selection. First, the slower ‘spread’ of EP–3 and EP may be an artifact of a sampling policy bias in case isolation: testing and quarantine were preferentially applied to travellers who had recently visited Wuhan, which may have led to selective detection, isolation, and tracing of these haplotypes rather than those with mutations occurring within Europe (e.g. C14408U and G25563U). (However, the EP+1 and EP+1+LOF haplotypes also increase faster in the late founder group, where it is unclear which haplotype was more travel-related.) Second, it is possible that the EP haplotype was effectively controlled, while EP+1 was introduced independently (<xref ref-type="bibr" rid="bib88">Worobey et al., 2020</xref>). Third, although G25563U itself simultaneously causes ORF3a-Q57H, ORF3c-R36I, and ORF3d-E14* (<italic>ORF3d</italic>-LOF), its spread seems to be linked with RdRp-P323L and Spike-D614G, a variant with predicted functional relevance (e.g. see <xref ref-type="bibr" rid="bib49">Korber et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Plante et al., 2020</xref>; <xref ref-type="bibr" rid="bib93">Yurkovetskiy et al., 2020</xref>). Thus, it is possible that G25563U is neutral while a linked variant(s) is under selection. These observations highlight the necessity of empirically evaluating the effects of these mutations and their interactions. Lastly, because only five major polymorphisms are considered in this analysis (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), it is possible that the spread of <italic>ORF3d</italic>-LOF or other haplotypes was further assisted or hindered by subsequent mutations.</p><p>Our study has several limitations. First, we were not able to confirm the translation of ORF3d using mass spectrometry (MS). This may be due to several reasons: (1) ORF3d may be expressed at low levels; (2) ORF3d is short, and tryptic digestion of ORF3d generates only two peptides potentially detectable by MS; (3) the tryptic peptides derived from ORF3d may not be amenable to detection by MS even under the best possible conditions, as suggested by its relatively low MS intensity even in an overexpression experiment (‘ORF3b’ in <xref ref-type="bibr" rid="bib32">Gordon et al., 2020</xref>); and (4) hitherto unknown post-translational modifications of ORF3d could prohibit detection. Other possibilities for validation of ORF3d include MS with other virus samples; affinity purification MS; fluorescent tagging and cell imaging; Western blotting; and the sequencing of additional genomes in this virus species, which would potentiate more powerful tests of purifying selection and a better understanding of the history and origin of <italic>ORF3d</italic>. With respect to between-host diversity, we focused on consensus-level sequence data; however, this approach can miss important variation (<xref ref-type="bibr" rid="bib39">Holmes, 2009</xref>), stressing the importance of deeply sequenced within-host samples using technology appropriate for calling within-host variants (<xref ref-type="bibr" rid="bib35">Grubaugh et al., 2019</xref>). As we use Wuhan-Hu-1 for reference-based read mapping and remove duplicate reads as possible PCR artifacts, reference bias (<xref ref-type="bibr" rid="bib21">Degner et al., 2009</xref>) or bias against natural duplicates at high-coverage loci (<xref ref-type="bibr" rid="bib96">Zhou et al., 2014</xref>) could potentially affect our within-host results. Additionally, we detected natural selection using so-called 'counting' methods that examine all pairwise comparisons between or within specific groups of sequences, which may have less power than methods that trace changes over a phylogeny. However, this approach is robust to errors in phylogenetic and ancestral sequence reconstruction, and to artifacts due to linkage or recombination (<xref ref-type="bibr" rid="bib40">Hughes et al., 2006</xref>; <xref ref-type="bibr" rid="bib66">Nelson and Hughes, 2015</xref>). Additionally, although our method for measuring selection in OLGs does not explicitly account for mutation bias, benchmarking suggests inference of purifying selection is conservative (<xref ref-type="bibr" rid="bib64">Nelson et al., 2020a</xref>). Finally, given multiple recombination breakpoints in <italic>ORF3a</italic> (<xref ref-type="bibr" rid="bib9">Boni et al., 2020</xref>) and the relative paucity of sequence data for viruses closely related to SARS-CoV-2, our analysis could not differentiate between convergence, recombination, or recurrent loss in the origin of <italic>ORF3d</italic>.</p><p>In conclusion, OLGs are an important part of viral biology and deserve more attention. We document several lines of evidence for the expression and functionality of a novel OLG in SARS-CoV-2, <italic>ORF3d</italic>, and compare it to other hypothesized OLG candidates in <italic>ORF3a</italic>. Finally, as a resource for future studies, we provide a detailed annotation of the SARS-CoV-2 genome and highlight mutations of potential relevance to the within- and between-host evolution of SARS-CoV-2.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Data and software</title><p>Supplementary scripts and documentation are freely available on GitHub at <ext-link ext-link-type="uri" xlink:href="https://github.com/chasewnelson/SARS-CoV-2-ORF3d">https://github.com/ chasewnelson/SARS-CoV-2-ORF3d</ext-link> (<xref ref-type="bibr" rid="bib65">Nelson et al., 2020b</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:469689991e7dbce2be4c4f618584304d91841c49">swh:1:rev:469689991e7dbce2be4c4f618584304d91841c49</ext-link>). Supplementary data not included in main figure source data are freely available on Zenodo at <ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/4052729">https://zenodo.org/record/4052729</ext-link>.</p></sec><sec id="s4-2"><title>Genomic features and coordinates</title><p>All genome coordinates are given with respect to the Wuhan-Hu-1 reference sequence (NCBI: NC_045512.2; GISAID: EPI_ISL_402125) unless otherwise noted. SARS-CoV (SARS-CoV-1) genome coordinates are given with respect to the Tor2 reference sequence (NC_004718.3). SARS-CoV-2 Uniprot peptides were obtained from <ext-link ext-link-type="uri" xlink:href="https://viralzone.expasy.org/8996">https://viralzone.expasy.org/8996</ext-link>, where <italic>ORF9c</italic> is currently referred to as <italic>ORF14</italic>. Nucleotide sequences were translated using R::Biostrings (<xref ref-type="bibr" rid="bib55">Lawrence et al., 2013</xref>), Biopython (<xref ref-type="bibr" rid="bib15">Cock et al., 2009</xref>), or SNPGenie (<xref ref-type="bibr" rid="bib63">Nelson et al., 2015</xref>). Alignments were viewed and edited in AliView v1.20 (<xref ref-type="bibr" rid="bib54">Larsson, 2014</xref>). To identify overlapping genes (OLGs) using the codon permutation method of <xref ref-type="bibr" rid="bib77">Schlub et al., 2018</xref>, all 12 open reading frames (ORFs) annotated in Wuhan-Hu-1 were used as a reference (<italic>ORF1a</italic>, <italic>ORF1b</italic>, <italic>S</italic>, <italic>ORF3a</italic>, <italic>E</italic>, <italic>M</italic>, <italic>ORF6</italic>, <italic>ORF7a</italic>, <italic>ORF7b</italic>, <italic>ORF8</italic>, <italic>N</italic>, and <italic>ORF10</italic>) (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Only forward-strand (same-strand; sense-sense) OLGs were considered in the codon permutation analysis.</p></sec><sec id="s4-3"><title>SARS-CoV-2 genome data, alignments, and between-host analyses</title><p>SARS-CoV-2 genome sequences were obtained from GISAID on April 10, 2020 (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Whole genomes were aligned using MAFFT v7.455 (<xref ref-type="bibr" rid="bib45">Katoh and Standley, 2013</xref>), and subsequently discarded if they contained internal gaps (-) located &gt;900 nt from either terminus, a distance sufficient to exclude sequences with insertions or deletions (indels) in protein-coding regions. A total of 3978 sequences passed these filtering criteria, listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. Coding regions were identified using exact or partial homology to SARS-CoV-2 or SARS-CoV annotations. To quantify the diversity and evenness of sample locations, we quantified their entropy as -∑<italic>p</italic>*ln(<italic>p</italic>), where <italic>p</italic> is the number of distinct (unique) locations or countries reported for a given window (<xref ref-type="bibr" rid="bib23">Ewens and Grant, 2001</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></sec><sec id="s4-4"><title><italic>Severe acute respiratory syndrome-related coronavirus</italic> genome data and alignments</title><p><italic>Severe acute respiratory syndrome-related coronavirus</italic> genome IDs were obtained from <xref ref-type="bibr" rid="bib51">Lam et al., 2020</xref> and downloaded from GenBank or GISAID. Wuhan-Hu-1 was used to represent SARS-CoV-2. Unless otherwise noted, isolates GX/P5L (NCBI: MT040335.1; GISAID: EPI_ISL_410540) and GD/1 (GISAID: EPI_ISL_410721) were used to represent pangolin-COVs; GD/1 was chosen as a representative because the other Guangdong (GD) sequence lacks the <italic>S</italic> gene and contains 27.76% Ns, while GX/P5L was chosen because it is one of two high-coverage Guangxi (GX) sequences derived from lung tissue that also contains no undetermined nucleotides (Ns). Other sequences were excluded if they lacked an annotated <italic>ORF1ab</italic> with a ribosomal slippage, or contained a frameshift indel in any gene (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), leaving 21 sequences for analysis (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><p>To produce whole-genome alignments, we first aligned all genome sequences using MAFFT. Then, coding regions were identified using exact or partial sequence identity to SARS-CoV-2 or SARS-CoV annotations, translated, and individually aligned at the amino acid level using ProbCons v1.12 (<xref ref-type="bibr" rid="bib22">Do et al., 2005</xref>). In the case of OLGs, the longest (reference) protein was used (e.g. N rather than ORF9b or ORF9c). Amino acid alignments were then imposed on the coding sequence of each gene using PAL2NAL v14 (<xref ref-type="bibr" rid="bib81">Suyama et al., 2006</xref>) to maintain intact codons. Finally, whole genomes were manually shifted to match the individual codon alignments in AliView. Codon breaks were preferentially resolved to align S/Q/T at 3337–3339, and L/T/I at 3343–3345. This preserved all nucleotides of each genome while concurrently producing codon-aware alignments. The alignment is available in the supplementary data as SARS-related-CoV_ALN.fasta, where pangolin-CoV GD/1 has been masked (Ns) because it is only available from GISAID (i.e. permission is required for data access).</p><p>Phylogenetic relationships among isolates were explored using maximum likelihood phylogenetic inference, as implemented in IQ-tree (<xref ref-type="bibr" rid="bib67">Nguyen et al., 2015</xref>), using the generalized time-reversible (GTR; <xref ref-type="bibr" rid="bib82">Tavaré, 1986</xref>) substitution model combined with the FreeRate model (<xref ref-type="bibr" rid="bib80">Soubrier et al., 2012</xref>) to account for among-site rate heterogeneity. Trees were rooted a priori following <xref ref-type="bibr" rid="bib51">Lam et al., 2020</xref>.</p></sec><sec id="s4-5"><title>Proteomics analysis</title><p>We used MaxQuant (<xref ref-type="bibr" rid="bib17">Cox and Mann, 2008</xref>) to re-analyze five publicly available SARS-CoV-2 mass spectrometry (MS) datasets: <xref ref-type="bibr" rid="bib7">Bezstarosti et al., 2020</xref> (PRIDE accession PXD018760); <xref ref-type="bibr" rid="bib8">Bojkova et al., 2020</xref> (PXD017710); <xref ref-type="bibr" rid="bib20">Davidson et al., 2020</xref> (PXD018241); PRIDE Project PXD018581; and <xref ref-type="bibr" rid="bib94">Zecha et al., 2020</xref> (PXD019645). However, peptide spectrum matches for ORF3d (possible tryptic peptides CTSCCFSER and FQNHNPQK) did not pass our 1% false-discovery threshold in any of these datasets, and ORF3d-2 (<xref ref-type="table" rid="table1">Table 1</xref>) does not encode any peptides detectable by this method. ORF3c, ORF9c, and ORF10 could also not be reliably detected. For peptides that were successfully detected in the datasets of <xref ref-type="bibr" rid="bib7">Bezstarosti et al., 2020</xref> and <xref ref-type="bibr" rid="bib20">Davidson et al., 2020</xref>, protein concentrations were estimated using intensity-based absolute quantification (iBAQ) (<xref ref-type="bibr" rid="bib78">Schwanhäusser et al., 2011</xref>). iBAQ values were computed using the Max-Quant software (<xref ref-type="bibr" rid="bib83">Tyanova et al., 2016</xref>) as the sum of all peptide intensities per protein divided by the number of theoretical peptides per protein. Thus, iBAQ values are proportional estimates of the molar protein quantity of a protein in a given sample, allowing relative quantitative comparisons of protein expression levels.</p></sec><sec id="s4-6"><title>Ribosome profiling analysis</title><p>The 16 ribosome profiling (Ribo-seq) datasets of <xref ref-type="bibr" rid="bib24">Finkel et al., 2020</xref> using SARS-CoV-2 infected Vero E6 cells were downloaded from the Sequence Read Archive (accession numbers SRR11713354-SRR11713369). These samples comprise four treatments for ribosome stalling: (1) lactimidomycin (LTM) or (2) harringtonine (Harr), which are biased towards stalling at translation initiation sites; (3) cyclohexamide (CHX), which stalls along a gene during active translation; and (4) mRNA, which serves as a control (i.e. total RNA content rather than ribosome footprints). Two time points are represented: (1) 5 hr and (2) 24 hr post-infection (hpi), labeled ‘05 hr’ and ‘4 hr’, respectively, in the SRA data. The FASTQ format reads were mapped to Wuhan-Hu-1 using Bowtie2 local alignment (<xref ref-type="bibr" rid="bib52">Langmead et al., 2019</xref>), with a seed length of 20 and up to one mismatch allowed, after substituting the isolate’s mutations listed in <xref ref-type="bibr" rid="bib24">Finkel et al., 2020</xref> into the reference genome. Mapped reads were then classified by read length and trimmed to their first (5′-end) nucleotide for downstream analyses.</p></sec><sec id="s4-7"><title>NetMHCpan T cell epitope analysis</title><p>For predicted MHC class I binding, viral protein sequences were analyzed in 9 amino acid (aa) substrings using NetMHCpan4.0 (<xref ref-type="bibr" rid="bib44">Jurtz et al., 2017</xref>). Twelve (12) representative HLA class I alleles (<xref ref-type="bibr" rid="bib79">Sidney et al., 2008</xref>) were tested: HLA-A*01:01 (A1), HLA-A*02:01 (A2), HLA-A*03:01 (A3), HLA-A*24:02 (A24), HLA-A*26:01 (A26), HLA-B*07:02 (B7), HLA-B*08:01 (B8), HLA-B*27:05 (B27), HLA-B*39:01 (B39), HLA-B*40:01 (B44), HLA-B*58:01 (B58), and HLA-B*15:01 (B62). NetMHCpan4.0 returns percentile ranks that characterize a peptide’s likelihood of antigen presentation compared to a set of random natural peptides. We employed the suggested threshold of 2% to determine potential presented peptides, and 0.5% to identify strong MHC class I binders. Both strong and weak binders were considered predicted epitopes. For predicted MHC class II binding, viral protein sequences were analyzed in 15 aa substrings using NetMHCIIpan4.0 (<xref ref-type="bibr" rid="bib73">Reynisson et al., 2020</xref>). Twenty-six (26) representative HLA class II alleles (<xref ref-type="bibr" rid="bib33">Greenbaum et al., 2011</xref>; <xref ref-type="bibr" rid="bib68">Paul et al., 2016</xref>) were tested: HLA-DPA1*0201-DPB1*0401, HLA-DPA1*0103-DPB1*0201, HLA-DPA1*0201-DPB1*0101, HLA-DPA1*0201-DPB1*0501, HLA-DPA1*0301-DPB1*0402, HLA-DQA1*0101-DQB1*0501, HLA-DQA1*0102-DQB1*0602, HLA-DQA1*0301-DQB1*0302, HLA-DQA1*0401-DQB1*0402, HLA-DQA1*0501-DQB1*0201, HLA-DQA1*0501-DQB1*0301, DRB1*0101, DRB1*0301, DRB1*0401, DRB1*0405, DRB1*0701, DRB1*0802, DRB1*0901, DRB1*1101, DRB1*1201, DRB1*1302, DRB1*1501, DRB3*0101, DRB3*0202, DRB4*0101, and DRB5*0101. NetMHCIIpan4.0 returns percentile ranks based on an eluted ligand prediction score. We employed the suggested threshold of 10% to determine potential presented peptides, and 2% to identify strong MHC class II binders. Both strong and weak binders were considered predicted epitopes.</p></sec><sec id="s4-8"><title>Hydrophobicity profile analysis</title><p>The sequence of <italic>ORF3a</italic> was translated in all three forward-strand reading frames and uploaded to the VOLPES server (<ext-link ext-link-type="uri" xlink:href="http://volpes.univie.ac.at/">http://volpes.univie.ac.at/</ext-link>; <xref ref-type="bibr" rid="bib4">Bartonek and Zagrovic, 2019</xref>) to determine hydrophobicity profiles using the unitless scale ‘FAC1’ (Factor 1; <xref ref-type="bibr" rid="bib2">Atchley et al., 2005</xref>) with a window size of 25 aa. The correlations between the profiles for the reading frames were calculated for peptides encoded by the following subregions of <italic>ORF3a</italic>, from 5′ to 3′: (1) '<italic>ORF3a</italic>', codons not overlapping any known or hypothesized overlapping genes; (2) '<italic>ORF3a</italic>/<italic>ORF3c</italic>', encoding residues of both ORF3a and ORF3c; (3) '<italic>ORF3a</italic>/<italic>ORF3c</italic>/<italic>ORF3d</italic>', encoding residues of ORF3a, ORF3c, and ORF3d; (4) '<italic>ORF3a</italic>/<italic>ORF3d</italic>', encoding residues of both ORF3a and ORF3d; and (5) '<italic>ORF3a</italic>/<italic>ORF3b</italic>', encoding residues of both ORF3a and ORF3b. Spearman’s rank correlation was computed using stats::cor.test with method='spearman' in R, treating mean 25-residue window values as the observational unit.</p></sec><sec id="s4-9"><title>Statistics and tests of natural selection</title><p>All p-values reported in this study are two-tailed. Statistical and data analyses and visualization were carried out in R v3.5.2 (<xref ref-type="bibr" rid="bib71">R Development Core Team, 2018</xref>) (libraries: boot, feather, ggrepel, patchwork, RColorBrewer, scales, tidyverse), Python (BioPython, pandas) (<xref ref-type="bibr" rid="bib59">McKinney, 2010</xref>), Microsoft Excel, Google Sheets, and PowerPoint. Colors were explored using Coolors (<ext-link ext-link-type="uri" xlink:href="https://coolors.co">https://coolors.co</ext-link>). Copyright-free images of a bat, human, and pangolin were obtained from Pixabay (<ext-link ext-link-type="uri" xlink:href="https://pixabay.com">https://pixabay.com</ext-link>). All <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> or <italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub> ratios were estimated for non-OLG regions using SNPGenie scripts snpgenie.pl or snpgenie_within_group.pl (<xref ref-type="bibr" rid="bib63">Nelson et al., 2015</xref>; <ext-link ext-link-type="uri" xlink:href="https://github.com/chasewnelson/SNPGenie">https://github.com/chasewnelson/SNPGenie</ext-link>), and for OLG regions using OLGenie script OLGenie.pl (<xref ref-type="bibr" rid="bib64">Nelson et al., 2020a</xref>; <ext-link ext-link-type="uri" xlink:href="https://github.com/chasewnelson/OLGenie">https://github.com/chasewnelson/OLGenie</ext-link>). All OLG <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> (<italic>π</italic><sub>N</sub>/<italic>π</italic><sub>S</sub>) estimates refer to <italic>d</italic><sub>NN</sub>/<italic>d</italic><sub>SN</sub> (<italic>π</italic><sub>NN</sub>/<italic>π</italic><sub>SN</sub>) for the reference frame and <italic>d</italic><sub>NN</sub>/<italic>d</italic><sub>NS</sub> (<italic>π</italic><sub>NN</sub>/<italic>π</italic><sub>NS</sub>) for the alternate frame (ss12 or ss13), as described in <xref ref-type="bibr" rid="bib64">Nelson et al., 2020a</xref>, because the number of SS (synonymous/synonymous) sites was insufficient to estimate <italic>d</italic><sub>SS</sub> (<italic>π</italic><sub>SS</sub>). The null hypothesis that <italic>d</italic><sub>N</sub>-<italic>d</italic><sub>S</sub> = 0 (<italic>π</italic><sub>N</sub>-<italic>π</italic><sub>S</sub> = 0) was evaluated using both <italic>Z</italic> and achieved significance level (ASL) tests (<xref ref-type="bibr" rid="bib62">Nei and Kumar, 2000</xref>) with 10,000 and 1000 bootstrap replicates for genes and sliding windows, respectively, using individual codons (alignment columns) as the resampling unit (<xref ref-type="bibr" rid="bib62">Nei and Kumar, 2000</xref>). The main text reports only <italic>Z</italic>-test results, because this test was used to benchmark OLGenie (<xref ref-type="bibr" rid="bib64">Nelson et al., 2020a</xref>) and appears to be more conservative. For ASL, p-values of 0 were reported as the lowest non-zero value possible given the number of bootstrap replicates. Benjamini-Hochberg (<xref ref-type="bibr" rid="bib5">Benjamini and Hochberg, 1995</xref>) or Benjamini-Yekutieli (<xref ref-type="bibr" rid="bib6">Benjamini and Yekutieli, 2001</xref>) false-discovery rate corrections (<italic>Q</italic>-values) were used for genes (independent regions) and sliding windows (contiguous overlapping regions), respectively.</p></sec><sec id="s4-10"><title>Between-species analyses</title><p>Because uncorrected <italic>d</italic> values &gt;0.1 were observed in between-taxa comparisons, a Jukes-Cantor correction (<xref ref-type="bibr" rid="bib42">Jukes and Cantor, 1969</xref>) was applied to <italic>d</italic><sub>N</sub> and <italic>d</italic><sub>S</sub> estimates. For each ORF, sequences were only used to estimate <italic>d</italic><sub>N</sub>/<italic>d</italic><sub>S</sub> if a complete, intact ORF (no STOPs) was present. Most notably, for <italic>ORF3b</italic>, only the region corresponding to the first ORF in SARS-CoV-2 was analyzed, and these sites were also considered an OLG region of <italic>ORF3a</italic>. The remaining 3’-proximal portion of <italic>ORF3a</italic> (codons 165–276) was considered a non-OLG region, and only genomes lacking the full-length <italic>ORF3b</italic> (i.e. those with mid-sequence STOP codons) were included in these estimates. Similarly, for <italic>ORF3d</italic>, only SARS-CoV-2 and pangolin-CoV GX/P5L were analyzed for <xref ref-type="fig" rid="fig5">Figure 5</xref>. For this analysis, <italic>ORF3a</italic> codon 71 in SARS-CoV-2 (CTA) differed by two nucleotides from the codon in pangolin-CoV GX/P5L (TTT), resulting in a multi-hit approximation being employed by the OLGenie method (<xref ref-type="bibr" rid="bib64">Nelson et al., 2020a</xref>). Thus, for greater accuracy, we instead estimated changes in this codon using the method of <xref ref-type="bibr" rid="bib85">Wei and Zhang, 2015</xref> across two mutational pathways, which yields 0.5 nonsynonymous/nonsynonymous, 0.5 nonsynonymous/synonymous, and 1.0 synonymous/nonsynonymous changes. The region occupied by the triple overlap of <italic>ORF3a</italic>/<italic>ORF3c</italic>/<italic>ORF3d</italic> (<italic>ORF3a</italic> codons 44–64; <xref ref-type="table" rid="table1">Table 1</xref>) was excluded from analysis for all three genes. The following codons (or their homologous positions) were also excluded from all analyses: all codons occupying a non-OLG/OLG boundary; codons 4460–4466 of <italic>ORF1ab</italic>, which constitute either <italic>nsp11</italic> or <italic>nsp12</italic> depending on a ribosomal frameshift; codons 1–13 of <italic>E</italic>, which overlap <italic>ORF3b</italic> in some genomes; codons 62–64 of <italic>ORF6</italic>, which follow a premature STOP in some genomes; codons 122–124 of <italic>ORF7a</italic> and 1–3 of <italic>ORF7b</italic>, which overlap each other; and codons 72–74 of <italic>ORF9c</italic>, which follow a premature STOP in some genomes.</p></sec><sec id="s4-11"><title>Cumulative haplotype frequencies</title><p>We defined haplotypes along the mutational path to EP+1+LOF using all five high-derived allele frequency (DAF) mutations from Wuhan-Hu-1 to <italic>ORF3d</italic>-LOF. Subsequent mutations after <italic>ORF3d</italic>-LOF were ignored in the haplotype analysis. Samples with missing data at any of the five loci were also ignored. We calculated the cumulative frequency of each haplotype in Germany (where the EP haplotype is a documented founder) and five other countries with the most abundant samples at the time of data accession. Cumulative frequencies were calculated as the total number of occurrences of each haplotype collected on or before each day, divided by the total number of samples from the same country. Countries were subsequently divided into early founders and late founders to investigate founder effects, where early founder countries tend to have several samples from January, and late founder countries tend to have samples collected only after mid-February.</p></sec><sec id="s4-12"><title>Within-host diversity</title><p>For within-host analyses, we obtained <italic>n</italic> = 401 high-depth (at least 50-fold mean coverage) human SARS-CoV-2 samples from the Sequence Read Archive (listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Only Illumina samples were used, as some Nanopore samples exhibit apparent systematic bias in calling putative intrahost SNPs, and this technology has also been shown to be unsuitable for intra-host analysis (<xref ref-type="bibr" rid="bib35">Grubaugh et al., 2019</xref>). Reads were trimmed with BBTools BBDUK (<xref ref-type="bibr" rid="bib10">Bushnell, 2017</xref>) and mapped against the Wuhan-Hu-1 reference sequence using Bowtie2 (<xref ref-type="bibr" rid="bib53">Langmead and Salzberg, 2012</xref>) with local alignment, seed length 20, and up to one mismatch. SNPs were called from mapped reads using the LoFreq (<xref ref-type="bibr" rid="bib87">Wilm et al., 2012</xref>) variant caller, requiring both sequencing quality and MAPQ to be ≥30. Only single-end or the first of paired-end reads were used. Within-host variants were dynamically filtered based on each site’s coverage using a binomial cutoff to ensure a false-discovery rate of ≤1 across our entire study (401 samples), assuming a mean sequencing error rate of 0.2% (<xref ref-type="bibr" rid="bib76">Schirmer et al., 2016</xref>).</p><p>To estimate <italic>π</italic>, numbers of nonsynonymous and synonymous differences and sites were first calculated individually for all genes in each of the 401 samples using SNPGenie (<xref ref-type="bibr" rid="bib63">Nelson et al., 2015</xref>; snpgenie.pl, <ext-link ext-link-type="uri" xlink:href="https://github.com/chasewnelson/SNPGenie">https://github.com/chasewnelson/SNPGenie</ext-link>). OLG regions were then analyzed separately using OLGenie (<xref ref-type="bibr" rid="bib64">Nelson et al., 2020a</xref>; OLGenie.pl, <ext-link ext-link-type="uri" xlink:href="https://github.com/chasewnelson/OLGenie">https://github.com/chasewnelson/OLGenie</ext-link>). Because OLGenie requires a multiple sequence alignment as input, a pseudo-alignment of 1000 sequences was constructed for each OLG region in each sample by randomly substituting single nucleotide variants according to their within-host frequencies into the Wuhan-Hu-1 reference genome. For non-OLG and OLG regions alike, average within-host numbers of differences and sites were calculated for each codon by taking the mean across all samples. For example, if a particular codon contained nonsynonymous differences in two of 401 samples, with the two samples exhibiting mean numbers of 0.01 and 0.002 pairwise differences per site, this codon was considered to exhibit a mean of (0.01+0.002)/401 = 0.0000299 pairwise differences per site across all samples. These codon means were then treated as independent units of observation during bootstrapping.</p><p>Pangolin samples refer to Sequence Read Archive records SRR11093266, SRR11093267, SRR11093268, SRR11093269, SRR11093270, and SRR11093271. Only 179 single nucleotide variants could be called prior to our FDR filtering, and samples SRR11093271 and SRR11093270 were discarded entirely due to low mapping quality. We also note that after our quality filtering, four samples contain consensus alleles that do not match their reference sequence (available from GISAID): P1E, P4L, P5E, and P5L (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></sec><sec id="s4-13"><title>Within-host recurrent mutations analyses</title><p>We assume that each host was infected by a single genotype. Under this assumption, the minor allele at each segregating site within-host is either due to genotyping or sequencing artifacts, or new mutations. Because there are very few loci with high-frequency derived alleles between hosts, and because Wuhan-Hu-1 is used as the reference in read mapping, we here only consider within-host mutations that differ from this reference background. There are four possible bases at each locus (A, C, G, and U), and three possible mutational changes away from the reference. For each locus, we calculated the number of samples matching the reference allele as <italic>N </italic>= <italic>N</italic><sub>1</sub>+<italic>N</italic><sub>2</sub>, where <italic>N</italic><sub>1</sub> is the number of samples in which the Wuhan-Hu-1 reference allele is the only observed allele (fixed), and <italic>N</italic><sub>2</sub> is the number of samples in which the site is polymorphic but the reference allele is still the major (most common) allele. Given <italic>N</italic><sub>2</sub>, we further determined the number of samples carrying each of the three possible non-reference alleles as <italic>N</italic><sub>A</sub>, <italic>N</italic><sub>C</sub>, <italic>N</italic><sub>G</sub>, and <italic>N</italic><sub>U</sub>. For example, if the reference allele was U, we calculated <italic>p</italic><sub>A</sub>, <italic>p</italic><sub>C</sub>, and <italic>p</italic><sub>G</sub>, where <italic>p</italic><sub>All</sub> = <italic>p</italic><sub>A</sub>+<italic>p</italic><sub>C</sub>+<italic>p</italic><sub>G</sub>. If A was an observed non-reference allele, we calculated the frequency of A among samples as <italic>p</italic><sub>A</sub> = <italic>N</italic><sub>A</sub>/<italic>N</italic>. Thus, a larger frequency indicates the derived allele is observed in a higher proportion of samples (<xref ref-type="fig" rid="fig8">Figure 8</xref>). The within-host derived allele frequency (DAF) for each sample was estimated as the total number of reads matching the observed minor allele divided by the total number of reads mapped to the locus. If all reads matched the reference allele, then DAF = 0. Five mutations (four nonsynonymous) occur in ≥10% of samples (after rounding to the nearest percent), with their DAFs plotted in <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>. For this analysis, we did not apply the per-site FDR cutoff, thus a DAF = 0 is equivalent to the absence of mapped reads with the mutation, after reads are filtered by sequence quality, mapping quality, and LoFreq’s default significance threshold (p=0.01).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This work was supported by a Postdoctoral Research Fellowship from Academia Sinica (to CWN under PI Wen-Hsiung Li); funding from the Bavarian State Government and National Philanthropic Trust (to Z.A. under PI Siegfried Scherer); NSF IOS grants #1755370 and #1758800 (to S-OK); and the University of Wisconsin-Madison John D MacArthur Professorship Chair (to TLG). Copyright-free images were obtained from Pixabay. The authors thank the GISAID platform and the originating and submitting laboratories who kindly uploaded SARS-CoV-2 sequences to the GISAID EpiCov Database for public access (see <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, GISAID Acknowledgments Table). The authors thank Maciej F Boni, Reed A Cartwright, John Flynn, Kyle Friend, Dan Graur, Robert S Harbert, Cheryl Hayashi, David G Karlin, Niloufar Kavian, Kin-Hang (Raven) Kok, Wen-Hsiung Li, Meiyeh Lu, David A Matthews, Lisa Mirabello, Apurva Narechania, Felix Li Jin, and attendees of the UC Berkeley popgen journal club for useful information and discussion; Andrew E Firth, Alexander Gorbalenya, Irwin Jungreis, Manolis Kellis, Raven Kok, Angelo Pavesi, Kei Sato, Manuela Sironi, and Noam Stern-Ginossar for an invaluable discussion regarding standardizing nomenclature; Angelo Pavesi for pointing out that <italic>ORF3d</italic>-LOF causes a nonsynonymous change in <italic>ORF3c</italic>; Helen Piontkivska, Patricia Wittkopp, Antonis Rokas, and one anonymous reviewer for critical suggestions; Ming-Hsueh Lin for immense feedback on figures; and special thanks to Priya Moorjani, Jacob Tennessen, Montgomery Slatkin, Yun S Song, Jianzhi George Zhang, Xueying Li, Hongxiang Zheng, Qinqin Yu, Meredith Yeager, and Michael Dean for commenting on earlier drafts of this manuscript.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Software, Formal analysis, Validation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Formal analysis, Supervision, Methodology</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Software, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>SARSCoV2_ORF3d_supplementary_tables.xlsx.</title><p>Supplementary Tables; detailed descriptions given in the CONTENTS sheet.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59633-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>gisaid_hcov-19_acknowledgement_table_2020_04_28_08.xls.</title><p>List of laboratories submitting SARS-CoV-2 consensus-level genome sequences to the GISAID EpiCov Database for public access.</p></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-59633-supp2-v2.xls"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-59633-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supplement. Scripts and source data for all analyses and figures are provided on GitHub at <ext-link ext-link-type="uri" xlink:href="https://github.com/chasewnelson/SARS-CoV-2-ORF3d">https://github.com/chasewnelson/SARS-CoV-2-ORF3d</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:469689991e7dbce2be4c4f618584304d91841c49">https://archive.softwareheritage.org/swh:1:rev:469689991e7dbce2be4c4f618584304d91841c49</ext-link>) and Zenodo at <ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/4052729">https://zenodo.org/record/4052729</ext-link>. Samples SRR11713366, SRR11713367, SRR11713368, and SRR11713369 were used from the GSE149973 dataset. The EpiCoVTM database was accessed at <ext-link ext-link-type="uri" xlink:href="https://www.gisaid.org/">https://www.gisaid.org/</ext-link> and exact sequences used from this database (prior to filtering) are listed in Supplementary file 2.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Demmers</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>TARGETED PROTEOMICS FOR THE DETECTION OF SARS-COV-2 PROTEINS</data-title><source>PRIDE</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD018760">PXD018760</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Klann</surname><given-names>K</given-names></name><name><surname>Münch</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Proteome and Translatome of SARS-CoV-2 infected cells</data-title><source>PRIDE</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD017710">PXD017710</pub-id></element-citation></p><p><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Mari</surname><given-names>T</given-names></name><name><surname>Selbach</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Proteomics of SARS-CoV and SARS-CoV-2 infected cells</data-title><source>PRIDE</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD018581">PXD018581</pub-id></element-citation></p><p><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Finkel</surname><given-names>Y</given-names></name><name><surname>Mizrahi</surname><given-names>O</given-names></name><name><surname>Nachshon</surname><given-names>A</given-names></name><name><surname>Weingarten-Gabbay</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Decoding SARS-CoV-2 coding capacity</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE149973">GSE149973</pub-id></element-citation></p><p><element-citation id="dataset7" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CY</given-names></name><name><surname>Kuster</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Data, reagents, assays and merits of proteomics for SARS-CoV-2 research and testing</data-title><source>PRIDE</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD019645">PXD019645</pub-id></element-citation></p><p><element-citation id="dataset8" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Vero cells infected with SARS CoV 2 no quantitation slices 1-10 of 20</data-title><source>Zenodo</source><pub-id assigning-authority="Zenodo" pub-id-type="doi">10.5281/zenodo.3722590</pub-id></element-citation></p><p><element-citation id="dataset9" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>vero cells infected with SARS CoV2 slices 11-20 of 20 slices</data-title><source>Zenodo</source><pub-id assigning-authority="Zenodo" pub-id-type="doi">10.5281/zenodo.3722597</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Affram</surname> <given-names>Y</given-names></name><name><surname>Zapata</surname> <given-names>JC</given-names></name><name><surname>Gholizadeh</surname> <given-names>Z</given-names></name><name><surname>Tolbert</surname> <given-names>WD</given-names></name><name><surname>Zhou</surname> <given-names>W</given-names></name><name><surname>Iglesias-Ussel</surname> <given-names>MD</given-names></name><name><surname>Pazgier</surname> <given-names>M</given-names></name><name><surname>Ray</surname> <given-names>K</given-names></name><name><surname>Latinovic</surname> <given-names>OS</given-names></name><name><surname>Romerio</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The HIV-1 antisense protein ASP is a transmembrane protein of the cell surface and an integral protein of the viral envelope</article-title><source>Journal of Virology</source><volume>93</volume><elocation-id>e00574</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.00574-19</pub-id><pub-id pub-id-type="pmid">31434734</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atchley</surname> <given-names>WR</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Fernandes</surname> <given-names>AD</given-names></name><name><surname>Drüke</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Solving the protein sequence metric problem</article-title><source>PNAS</source><volume>102</volume><fpage>6395</fpage><lpage>6400</lpage><pub-id pub-id-type="doi">10.1073/pnas.0408677102</pub-id><pub-id pub-id-type="pmid">15851683</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartonek</surname> <given-names>L</given-names></name><name><surname>Braun</surname> <given-names>D</given-names></name><name><surname>Zagrovic</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Frameshifting preserves key physicochemical properties of proteins</article-title><source>PNAS</source><volume>117</volume><fpage>5907</fpage><lpage>5912</lpage><pub-id pub-id-type="doi">10.1073/pnas.1911203117</pub-id><pub-id pub-id-type="pmid">32127487</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartonek</surname> <given-names>L</given-names></name><name><surname>Zagrovic</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>VOLPES: an interactive web-based tool for visualizing and comparing physicochemical properties of biological sequences</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>W632</fpage><lpage>W635</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz407</pub-id><pub-id pub-id-type="pmid">31114895</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname> <given-names>Y</given-names></name><name><surname>Hochberg</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title><source>Journal of the Royal Statistical Society: Series B</source><volume>57</volume><fpage>289</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1111/j.2517-6161.1995.tb02031.x</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname> <given-names>Y</given-names></name><name><surname>Yekutieli</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The control of the false discovery rate in multiple testing under dependency</article-title><source>The Annals of Statistics</source><volume>29</volume><fpage>1165</fpage><lpage>1188</lpage><pub-id pub-id-type="doi">10.1214/aos/1013699998</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Bezstarosti</surname> <given-names>K</given-names></name><name><surname>Lamers</surname> <given-names>MM</given-names></name><name><surname>Haagmans</surname> <given-names>BL</given-names></name><name><surname>Demmers</surname> <given-names>JAA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Targeted proteomics for the detection of SARS-CoV-2 proteins</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.04.23.057810</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bojkova</surname> <given-names>D</given-names></name><name><surname>Klann</surname> <given-names>K</given-names></name><name><surname>Koch</surname> <given-names>B</given-names></name><name><surname>Widera</surname> <given-names>M</given-names></name><name><surname>Krause</surname> <given-names>D</given-names></name><name><surname>Ciesek</surname> <given-names>S</given-names></name><name><surname>Cinatl</surname> <given-names>J</given-names></name><name><surname>Münch</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Proteomics of SARS-CoV-2-infected host cells reveals therapy targets</article-title><source>Nature</source><volume>583</volume><fpage>469</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2332-7</pub-id><pub-id pub-id-type="pmid">32408336</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boni</surname> <given-names>MF</given-names></name><name><surname>Lemey</surname> <given-names>P</given-names></name><name><surname>Jiang</surname> <given-names>X</given-names></name><name><surname>Lam</surname> <given-names>TT-Y</given-names></name><name><surname>Perry</surname> <given-names>BW</given-names></name><name><surname>Castoe</surname> <given-names>TA</given-names></name><name><surname>Rambaut</surname> <given-names>A</given-names></name><name><surname>Robertson</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic</article-title><source>Nature Microbiology</source><volume>382</volume><elocation-id>4</elocation-id><pub-id pub-id-type="doi">10.1038/s41564-020-0771-4</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Bushnell</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><source>BBTools</source><ext-link ext-link-type="uri" xlink:href="https://jgi.doe.gov/data-and-tools/bbtools/">https://jgi.doe.gov/data-and-tools/bbtools/</ext-link></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cagliani</surname> <given-names>R</given-names></name><name><surname>Forni</surname> <given-names>D</given-names></name><name><surname>Clerici</surname> <given-names>M</given-names></name><name><surname>Sironi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses</article-title><source>Infection, Genetics and Evolution</source><volume>83</volume><elocation-id>104353</elocation-id><pub-id pub-id-type="doi">10.1016/j.meegid.2020.104353</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calviello</surname> <given-names>L</given-names></name><name><surname>Ohler</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Beyond read-counts: Ribo-seq data analysis to understand the functions of the transcriptome</article-title><source>Trends in Genetics</source><volume>33</volume><fpage>728</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2017.08.003</pub-id><pub-id pub-id-type="pmid">28887026</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassan</surname> <given-names>E</given-names></name><name><surname>Arigon-Chifolleau</surname> <given-names>AM</given-names></name><name><surname>Mesnard</surname> <given-names>JM</given-names></name><name><surname>Gross</surname> <given-names>A</given-names></name><name><surname>Gascuel</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Concomitant emergence of the antisense protein gene of HIV-1 and of the pandemic</article-title><source>PNAS</source><volume>113</volume><fpage>11537</fpage><lpage>11542</lpage><pub-id pub-id-type="doi">10.1073/pnas.1605739113</pub-id><pub-id pub-id-type="pmid">27681623</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname> <given-names>JF</given-names></name><name><surname>Kok</surname> <given-names>KH</given-names></name><name><surname>Zhu</surname> <given-names>Z</given-names></name><name><surname>Chu</surname> <given-names>H</given-names></name><name><surname>To</surname> <given-names>KK</given-names></name><name><surname>Yuan</surname> <given-names>S</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan</article-title><source>Emerging Microbes &amp; Infections</source><volume>9</volume><fpage>221</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1080/22221751.2020.1719902</pub-id><pub-id pub-id-type="pmid">31987001</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cock</surname> <given-names>PJ</given-names></name><name><surname>Antao</surname> <given-names>T</given-names></name><name><surname>Chang</surname> <given-names>JT</given-names></name><name><surname>Chapman</surname> <given-names>BA</given-names></name><name><surname>Cox</surname> <given-names>CJ</given-names></name><name><surname>Dalke</surname> <given-names>A</given-names></name><name><surname>Friedberg</surname> <given-names>I</given-names></name><name><surname>Hamelryck</surname> <given-names>T</given-names></name><name><surname>Kauff</surname> <given-names>F</given-names></name><name><surname>Wilczynski</surname> <given-names>B</given-names></name><name><surname>de Hoon</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Biopython: freely available Python tools for computational molecular biology and bioinformatics</article-title><source>Bioinformatics</source><volume>25</volume><fpage>1422</fpage><lpage>1423</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp163</pub-id><pub-id pub-id-type="pmid">19304878</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Coronaviridae Study Group of the International Committee on Taxonomy of Viruses</collab><name><surname>Gorbalenya</surname> <given-names>AE</given-names></name><name><surname>Baker</surname> <given-names>SC</given-names></name><name><surname>Baric</surname> <given-names>RS</given-names></name><name><surname>de Groot</surname> <given-names>RJ</given-names></name><name><surname>Drosten</surname> <given-names>C</given-names></name><name><surname>Gulyaeva</surname> <given-names>AA</given-names></name><name><surname>Haagmans</surname> <given-names>BL</given-names></name><name><surname>Lauber</surname> <given-names>C</given-names></name><name><surname>Leontovich</surname> <given-names>AM</given-names></name><name><surname>Neuman</surname> <given-names>BW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The species <italic>Severe acute respiratory syndrome-related coronavirus</italic>: classifying 2019-nCoV and naming it SARS-CoV-2</article-title><source>Nature Microbiology</source><volume>5</volume><fpage>536</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1038/s41564-020-0695-z</pub-id><pub-id pub-id-type="pmid">32123347</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification</article-title><source>Nature Biotechnology</source><volume>26</volume><fpage>1367</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1038/nbt.1511</pub-id><pub-id pub-id-type="pmid">19029910</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>F</given-names></name><name><surname>Shi</surname> <given-names>ZL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Origin and evolution of pathogenic coronaviruses</article-title><source>Nature Reviews Microbiology</source><volume>17</volume><fpage>181</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1038/s41579-018-0118-9</pub-id><pub-id pub-id-type="pmid">30531947</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daugherty</surname> <given-names>MD</given-names></name><name><surname>Malik</surname> <given-names>HS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Rules of engagement: molecular insights from host-virus arms races</article-title><source>Annual Review of Genetics</source><volume>46</volume><fpage>677</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-110711-155522</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname> <given-names>AD</given-names></name><name><surname>Williamson</surname> <given-names>MK</given-names></name><name><surname>Lewis</surname> <given-names>S</given-names></name><name><surname>Shoemark</surname> <given-names>D</given-names></name><name><surname>Carroll</surname> <given-names>MW</given-names></name><name><surname>Heesom</surname> <given-names>KJ</given-names></name><name><surname>Zambon</surname> <given-names>M</given-names></name><name><surname>Ellis</surname> <given-names>J</given-names></name><name><surname>Lewis</surname> <given-names>PA</given-names></name><name><surname>Hiscox</surname> <given-names>JA</given-names></name><name><surname>Matthews</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein</article-title><source>Genome Medicine</source><volume>12</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-020-00763-0</pub-id><pub-id pub-id-type="pmid">32723359</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degner</surname> <given-names>JF</given-names></name><name><surname>Marioni</surname> <given-names>JC</given-names></name><name><surname>Pai</surname> <given-names>AA</given-names></name><name><surname>Pickrell</surname> <given-names>JK</given-names></name><name><surname>Nkadori</surname> <given-names>E</given-names></name><name><surname>Gilad</surname> <given-names>Y</given-names></name><name><surname>Pritchard</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Effect of read-mapping biases on detecting allele-specific expression from RNA-sequencing data</article-title><source>Bioinformatics</source><volume>25</volume><fpage>3207</fpage><lpage>3212</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp579</pub-id><pub-id pub-id-type="pmid">19808877</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do</surname> <given-names>CB</given-names></name><name><surname>Mahabhashyam</surname> <given-names>MS</given-names></name><name><surname>Brudno</surname> <given-names>M</given-names></name><name><surname>Batzoglou</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>ProbCons: probabilistic consistency-based multiple sequence alignment</article-title><source>Genome Research</source><volume>15</volume><fpage>330</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1101/gr.2821705</pub-id><pub-id pub-id-type="pmid">15687296</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ewens</surname> <given-names>WJ</given-names></name><name><surname>Grant</surname> <given-names>GR</given-names></name></person-group><year iso-8601-date="2001">2001</year><source>Statistical Methods in Bioinformatics</source><publisher-name>Springer-Verlag</publisher-name></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkel</surname> <given-names>Y</given-names></name><name><surname>Mizrahi</surname> <given-names>O</given-names></name><name><surname>Nachshon</surname> <given-names>A</given-names></name><name><surname>Weingarten-Gabbay</surname> <given-names>S</given-names></name><name><surname>Morgenstern</surname> <given-names>D</given-names></name><name><surname>Yahalom-Ronen</surname> <given-names>Y</given-names></name><name><surname>Tamir</surname> <given-names>H</given-names></name><name><surname>Achdout</surname> <given-names>H</given-names></name><name><surname>Stein</surname> <given-names>D</given-names></name><name><surname>Israeli</surname> <given-names>O</given-names></name><name><surname>Beth-Din</surname> <given-names>A</given-names></name><name><surname>Melamed</surname> <given-names>S</given-names></name><name><surname>Weiss</surname> <given-names>S</given-names></name><name><surname>Israely</surname> <given-names>T</given-names></name><name><surname>Paran</surname> <given-names>N</given-names></name><name><surname>Schwartz</surname> <given-names>M</given-names></name><name><surname>Stern-Ginossar</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The coding capacity of SARS-CoV-2</article-title><source>Nature</source><volume>20</volume><elocation-id>1</elocation-id><pub-id pub-id-type="doi">10.1038/s41586-020-2739-1</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firth</surname> <given-names>AE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a</article-title><source>Journal of General Virology</source><volume>1</volume><elocation-id>e001469</elocation-id><pub-id pub-id-type="doi">10.1099/jgv.0.001469</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname> <given-names>JA</given-names></name><name><surname>Purushotham</surname> <given-names>D</given-names></name><name><surname>Choudhary</surname> <given-names>MNK</given-names></name><name><surname>Zhuo</surname> <given-names>X</given-names></name><name><surname>Fan</surname> <given-names>C</given-names></name><name><surname>Matt</surname> <given-names>G</given-names></name><name><surname>Li</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Exploring the coronavirus pandemic with the WashU Virus Genome Browser</article-title><source>Nature Genetics</source><volume>52</volume><fpage>986</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1038/s41588-020-0697-z</pub-id><pub-id pub-id-type="pmid">32908257</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forni</surname> <given-names>D</given-names></name><name><surname>Cagliani</surname> <given-names>R</given-names></name><name><surname>Clerici</surname> <given-names>M</given-names></name><name><surname>Sironi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Molecular evolution of human coronavirus genomes</article-title><source>Trends in Microbiology</source><volume>25</volume><fpage>35</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2016.09.001</pub-id><pub-id pub-id-type="pmid">27743750</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fung</surname> <given-names>SY</given-names></name><name><surname>Yuen</surname> <given-names>KS</given-names></name><name><surname>Ye</surname> <given-names>ZW</given-names></name><name><surname>Chan</surname> <given-names>CP</given-names></name><name><surname>Jin</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses</article-title><source>Emerging Microbes &amp; Infections</source><volume>9</volume><fpage>558</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1080/22221751.2020.1736644</pub-id><pub-id pub-id-type="pmid">32172672</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazave</surname> <given-names>E</given-names></name><name><surname>Chang</surname> <given-names>D</given-names></name><name><surname>Clark</surname> <given-names>AG</given-names></name><name><surname>Keinan</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Population growth inflates the per-individual number of deleterious mutations and reduces their mean effect</article-title><source>Genetics</source><volume>195</volume><fpage>969</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1534/genetics.113.153973</pub-id><pub-id pub-id-type="pmid">23979573</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Yuan</surname> <given-names>X</given-names></name><name><surname>Xiao</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Deng</surname> <given-names>T</given-names></name><name><surname>Yuan</surname> <given-names>Q</given-names></name><name><surname>Xiao</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The epidemiology and clinical information about COVID-19</article-title><source>European Journal of Clinical Microbiology &amp; Infectious Diseases</source><volume>39</volume><fpage>1011</fpage><lpage>1019</lpage><pub-id pub-id-type="doi">10.1007/s10096-020-03874-z</pub-id><pub-id pub-id-type="pmid">32291542</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorbalenya</surname> <given-names>AE</given-names></name><name><surname>Enjuanes</surname> <given-names>L</given-names></name><name><surname>Ziebuhr</surname> <given-names>J</given-names></name><name><surname>Snijder</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Nidovirales: evolving the largest RNA virus genome</article-title><source>Virus Research</source><volume>117</volume><fpage>17</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2006.01.017</pub-id><pub-id pub-id-type="pmid">16503362</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname> <given-names>DE</given-names></name><name><surname>Jang</surname> <given-names>GM</given-names></name><name><surname>Bouhaddou</surname> <given-names>M</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Obernier</surname> <given-names>K</given-names></name><name><surname>White</surname> <given-names>KM</given-names></name><name><surname>O'Meara</surname> <given-names>MJ</given-names></name><name><surname>Rezelj</surname> <given-names>VV</given-names></name><name><surname>Guo</surname> <given-names>JZ</given-names></name><name><surname>Swaney</surname> <given-names>DL</given-names></name><name><surname>Tummino</surname> <given-names>TA</given-names></name><name><surname>Hüttenhain</surname> <given-names>R</given-names></name><name><surname>Kaake</surname> <given-names>RM</given-names></name><name><surname>Richards</surname> <given-names>AL</given-names></name><name><surname>Tutuncuoglu</surname> <given-names>B</given-names></name><name><surname>Foussard</surname> <given-names>H</given-names></name><name><surname>Batra</surname> <given-names>J</given-names></name><name><surname>Haas</surname> <given-names>K</given-names></name><name><surname>Modak</surname> <given-names>M</given-names></name><name><surname>Kim</surname> <given-names>M</given-names></name><name><surname>Haas</surname> <given-names>P</given-names></name><name><surname>Polacco</surname> <given-names>BJ</given-names></name><name><surname>Braberg</surname> <given-names>H</given-names></name><name><surname>Fabius</surname> <given-names>JM</given-names></name><name><surname>Eckhardt</surname> <given-names>M</given-names></name><name><surname>Soucheray</surname> <given-names>M</given-names></name><name><surname>Bennett</surname> <given-names>MJ</given-names></name><name><surname>Cakir</surname> <given-names>M</given-names></name><name><surname>McGregor</surname> <given-names>MJ</given-names></name><name><surname>Li</surname> <given-names>Q</given-names></name><name><surname>Meyer</surname> <given-names>B</given-names></name><name><surname>Roesch</surname> <given-names>F</given-names></name><name><surname>Vallet</surname> <given-names>T</given-names></name><name><surname>Mac Kain</surname> <given-names>A</given-names></name><name><surname>Miorin</surname> <given-names>L</given-names></name><name><surname>Moreno</surname> <given-names>E</given-names></name><name><surname>Naing</surname> <given-names>ZZC</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Peng</surname> <given-names>S</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Shen</surname> <given-names>W</given-names></name><name><surname>Kirby</surname> <given-names>IT</given-names></name><name><surname>Melnyk</surname> <given-names>JE</given-names></name><name><surname>Chorba</surname> <given-names>JS</given-names></name><name><surname>Lou</surname> <given-names>K</given-names></name><name><surname>Dai</surname> <given-names>SA</given-names></name><name><surname>Barrio-Hernandez</surname> <given-names>I</given-names></name><name><surname>Memon</surname> <given-names>D</given-names></name><name><surname>Hernandez-Armenta</surname> <given-names>C</given-names></name><name><surname>Lyu</surname> <given-names>J</given-names></name><name><surname>Mathy</surname> <given-names>CJP</given-names></name><name><surname>Perica</surname> <given-names>T</given-names></name><name><surname>Pilla</surname> <given-names>KB</given-names></name><name><surname>Ganesan</surname> <given-names>SJ</given-names></name><name><surname>Saltzberg</surname> <given-names>DJ</given-names></name><name><surname>Rakesh</surname> <given-names>R</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Rosenthal</surname> <given-names>SB</given-names></name><name><surname>Calviello</surname> <given-names>L</given-names></name><name><surname>Venkataramanan</surname> <given-names>S</given-names></name><name><surname>Liboy-Lugo</surname> <given-names>J</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Huang</surname> <given-names>XP</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Wankowicz</surname> <given-names>SA</given-names></name><name><surname>Bohn</surname> <given-names>M</given-names></name><name><surname>Safari</surname> <given-names>M</given-names></name><name><surname>Ugur</surname> <given-names>FS</given-names></name><name><surname>Koh</surname> <given-names>C</given-names></name><name><surname>Savar</surname> <given-names>NS</given-names></name><name><surname>Tran</surname> <given-names>QD</given-names></name><name><surname>Shengjuler</surname> <given-names>D</given-names></name><name><surname>Fletcher</surname> <given-names>SJ</given-names></name><name><surname>O'Neal</surname> <given-names>MC</given-names></name><name><surname>Cai</surname> <given-names>Y</given-names></name><name><surname>Chang</surname> <given-names>JCJ</given-names></name><name><surname>Broadhurst</surname> <given-names>DJ</given-names></name><name><surname>Klippsten</surname> <given-names>S</given-names></name><name><surname>Sharp</surname> <given-names>PP</given-names></name><name><surname>Wenzell</surname> <given-names>NA</given-names></name><name><surname>Kuzuoglu-Ozturk</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>HY</given-names></name><name><surname>Trenker</surname> <given-names>R</given-names></name><name><surname>Young</surname> <given-names>JM</given-names></name><name><surname>Cavero</surname> <given-names>DA</given-names></name><name><surname>Hiatt</surname> <given-names>J</given-names></name><name><surname>Roth</surname> <given-names>TL</given-names></name><name><surname>Rathore</surname> <given-names>U</given-names></name><name><surname>Subramanian</surname> <given-names>A</given-names></name><name><surname>Noack</surname> <given-names>J</given-names></name><name><surname>Hubert</surname> <given-names>M</given-names></name><name><surname>Stroud</surname> <given-names>RM</given-names></name><name><surname>Frankel</surname> <given-names>AD</given-names></name><name><surname>Rosenberg</surname> <given-names>OS</given-names></name><name><surname>Verba</surname> <given-names>KA</given-names></name><name><surname>Agard</surname> <given-names>DA</given-names></name><name><surname>Ott</surname> <given-names>M</given-names></name><name><surname>Emerman</surname> <given-names>M</given-names></name><name><surname>Jura</surname> <given-names>N</given-names></name><name><surname>von Zastrow</surname> <given-names>M</given-names></name><name><surname>Verdin</surname> <given-names>E</given-names></name><name><surname>Ashworth</surname> <given-names>A</given-names></name><name><surname>Schwartz</surname> <given-names>O</given-names></name><name><surname>d'Enfert</surname> <given-names>C</given-names></name><name><surname>Mukherjee</surname> <given-names>S</given-names></name><name><surname>Jacobson</surname> <given-names>M</given-names></name><name><surname>Malik</surname> <given-names>HS</given-names></name><name><surname>Fujimori</surname> <given-names>DG</given-names></name><name><surname>Ideker</surname> <given-names>T</given-names></name><name><surname>Craik</surname> <given-names>CS</given-names></name><name><surname>Floor</surname> <given-names>SN</given-names></name><name><surname>Fraser</surname> <given-names>JS</given-names></name><name><surname>Gross</surname> <given-names>JD</given-names></name><name><surname>Sali</surname> <given-names>A</given-names></name><name><surname>Roth</surname> <given-names>BL</given-names></name><name><surname>Ruggero</surname> <given-names>D</given-names></name><name><surname>Taunton</surname> <given-names>J</given-names></name><name><surname>Kortemme</surname> <given-names>T</given-names></name><name><surname>Beltrao</surname> <given-names>P</given-names></name><name><surname>Vignuzzi</surname> <given-names>M</given-names></name><name><surname>García-Sastre</surname> <given-names>A</given-names></name><name><surname>Shokat</surname> <given-names>KM</given-names></name><name><surname>Shoichet</surname> <given-names>BK</given-names></name><name><surname>Krogan</surname> <given-names>NJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</article-title><source>Nature</source><volume>583</volume><fpage>459</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2286-9</pub-id><pub-id pub-id-type="pmid">32353859</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenbaum</surname> <given-names>J</given-names></name><name><surname>Sidney</surname> <given-names>J</given-names></name><name><surname>Chung</surname> <given-names>J</given-names></name><name><surname>Brander</surname> <given-names>C</given-names></name><name><surname>Peters</surname> <given-names>B</given-names></name><name><surname>Sette</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes</article-title><source>Immunogenetics</source><volume>63</volume><fpage>325</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1007/s00251-011-0513-0</pub-id><pub-id pub-id-type="pmid">21305276</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grifoni</surname> <given-names>A</given-names></name><name><surname>Sidney</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Scheuermann</surname> <given-names>RH</given-names></name><name><surname>Peters</surname> <given-names>B</given-names></name><name><surname>Sette</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2</article-title><source>Cell Host &amp; Microbe</source><volume>27</volume><fpage>671</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2020.03.002</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grubaugh</surname> <given-names>ND</given-names></name><name><surname>Gangavarapu</surname> <given-names>K</given-names></name><name><surname>Quick</surname> <given-names>J</given-names></name><name><surname>Matteson</surname> <given-names>NL</given-names></name><name><surname>De Jesus</surname> <given-names>JG</given-names></name><name><surname>Main</surname> <given-names>BJ</given-names></name><name><surname>Tan</surname> <given-names>AL</given-names></name><name><surname>Paul</surname> <given-names>LM</given-names></name><name><surname>Brackney</surname> <given-names>DE</given-names></name><name><surname>Grewal</surname> <given-names>S</given-names></name><name><surname>Gurfield</surname> <given-names>N</given-names></name><name><surname>Van Rompay</surname> <given-names>KKA</given-names></name><name><surname>Isern</surname> <given-names>S</given-names></name><name><surname>Michael</surname> <given-names>SF</given-names></name><name><surname>Coffey</surname> <given-names>LL</given-names></name><name><surname>Loman</surname> <given-names>NJ</given-names></name><name><surname>Andersen</surname> <given-names>KG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar</article-title><source>Genome Biology</source><volume>20</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-018-1618-7</pub-id><pub-id pub-id-type="pmid">30621750</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hachim</surname> <given-names>A</given-names></name><name><surname>Kavian</surname> <given-names>N</given-names></name><name><surname>Cohen</surname> <given-names>CA</given-names></name><name><surname>Chin</surname> <given-names>AWH</given-names></name><name><surname>Chu</surname> <given-names>DKW</given-names></name><name><surname>Mok</surname> <given-names>CKP</given-names></name><name><surname>Tsang</surname> <given-names>OTY</given-names></name><name><surname>Yeung</surname> <given-names>YC</given-names></name><name><surname>Perera</surname> <given-names>R</given-names></name><name><surname>Poon</surname> <given-names>LLM</given-names></name><name><surname>Peiris</surname> <given-names>JSM</given-names></name><name><surname>Valkenburg</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection</article-title><source>Nature Immunology</source><volume>21</volume><fpage>1293</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-0773-7</pub-id><pub-id pub-id-type="pmid">32807944</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmy</surname> <given-names>YA</given-names></name><name><surname>Fawzy</surname> <given-names>M</given-names></name><name><surname>Elaswad</surname> <given-names>A</given-names></name><name><surname>Sobieh</surname> <given-names>A</given-names></name><name><surname>Kenney</surname> <given-names>SP</given-names></name><name><surname>Shehata</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control</article-title><source>Journal of Clinical Medicine</source><volume>9</volume><elocation-id>1225</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9041225</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname> <given-names>EC</given-names></name><name><surname>Lipman</surname> <given-names>DJ</given-names></name><name><surname>Zamarin</surname> <given-names>D</given-names></name><name><surname>Yewdell</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Comment on &quot;Large-scale sequence analysis of avian influenza isolates&quot;</article-title><source>Science</source><volume>313</volume><elocation-id>1573b</elocation-id><pub-id pub-id-type="doi">10.1126/science.1131729</pub-id><pub-id pub-id-type="pmid">16973862</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Holmes</surname> <given-names>EC</given-names></name></person-group><year iso-8601-date="2009">2009</year><source>The Evolution and Emergence of RNA Viruses</source><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname> <given-names>A</given-names></name><name><surname>Friedman</surname> <given-names>R</given-names></name><name><surname>Glenn</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The future of data analysis in evolutionary genomics</article-title><source>Current Genomics</source><volume>7</volume><fpage>227</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.2174/138920206778426942</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingolia</surname> <given-names>NT</given-names></name><name><surname>Ghaemmaghami</surname> <given-names>S</given-names></name><name><surname>Newman</surname> <given-names>JR</given-names></name><name><surname>Weissman</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling</article-title><source>Science</source><volume>324</volume><fpage>218</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1126/science.1168978</pub-id><pub-id pub-id-type="pmid">19213877</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jukes</surname> <given-names>TH</given-names></name><name><surname>Cantor</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="1969">1969</year><chapter-title>Evolution of protein molecules</chapter-title><person-group person-group-type="editor"><name><surname>Munro</surname> <given-names>H. N</given-names></name></person-group><source>Mammalian Protein Metabolism</source><publisher-name>Academic Press</publisher-name><fpage>21</fpage><lpage>132</lpage></element-citation></ref><ref id="bib43"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Jungreis</surname> <given-names>I</given-names></name><name><surname>Sealfon</surname> <given-names>R</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Sarbecovirus comparative genomics elucidates gene content of SARS-CoV-2 and functional impact of COVID-19 pandemic mutations</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.06.02.130955</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurtz</surname> <given-names>V</given-names></name><name><surname>Paul</surname> <given-names>S</given-names></name><name><surname>Andreatta</surname> <given-names>M</given-names></name><name><surname>Marcatili</surname> <given-names>P</given-names></name><name><surname>Peters</surname> <given-names>B</given-names></name><name><surname>Nielsen</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>NetMHCpan-4.0: improved peptide–MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data</article-title><source>The Journal of Immunology</source><volume>199</volume><fpage>3360</fpage><lpage>3368</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1700893</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname> <given-names>K</given-names></name><name><surname>Standley</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MAFFT multiple sequence alignment software version 7: improvements in performance and usability</article-title><source>Molecular Biology and Evolution</source><volume>30</volume><fpage>772</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.1093/molbev/mst010</pub-id><pub-id pub-id-type="pmid">23329690</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keese</surname> <given-names>PK</given-names></name><name><surname>Gibbs</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Origins of genes: &quot;big bang&quot; or continuous creation?</article-title><source>PNAS</source><volume>89</volume><fpage>9489</fpage><lpage>9493</lpage><pub-id pub-id-type="doi">10.1073/pnas.89.20.9489</pub-id><pub-id pub-id-type="pmid">1329098</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konno</surname> <given-names>Y</given-names></name><name><surname>Kimura</surname> <given-names>I</given-names></name><name><surname>Uriu</surname> <given-names>K</given-names></name><name><surname>Fukushi</surname> <given-names>M</given-names></name><name><surname>Irie</surname> <given-names>T</given-names></name><name><surname>Koyanagi</surname> <given-names>Y</given-names></name><name><surname>Sauter</surname> <given-names>D</given-names></name><name><surname>Gifford</surname> <given-names>RJ</given-names></name><name><surname>Nakagawa</surname> <given-names>S</given-names></name><name><surname>Sato</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant</article-title><source>Cell Reports</source><volume>32</volume><elocation-id>108185</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108185</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopecky-Bromberg</surname> <given-names>SA</given-names></name><name><surname>Martínez-Sobrido</surname> <given-names>L</given-names></name><name><surname>Frieman</surname> <given-names>M</given-names></name><name><surname>Baric</surname> <given-names>RA</given-names></name><name><surname>Palese</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists</article-title><source>Journal of Virology</source><volume>81</volume><fpage>548</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1128/JVI.01782-06</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korber</surname> <given-names>B</given-names></name><name><surname>Fischer</surname> <given-names>WM</given-names></name><name><surname>Gnanakaran</surname> <given-names>S</given-names></name><name><surname>Yoon</surname> <given-names>H</given-names></name><name><surname>Theiler</surname> <given-names>J</given-names></name><name><surname>Abfalterer</surname> <given-names>W</given-names></name><name><surname>Hengartner</surname> <given-names>N</given-names></name><name><surname>Giorgi</surname> <given-names>EE</given-names></name><name><surname>Bhattacharya</surname> <given-names>T</given-names></name><name><surname>Foley</surname> <given-names>B</given-names></name><name><surname>Hastie</surname> <given-names>KM</given-names></name><name><surname>Parker</surname> <given-names>MD</given-names></name><name><surname>Partridge</surname> <given-names>DG</given-names></name><name><surname>Evans</surname> <given-names>CM</given-names></name><name><surname>Freeman</surname> <given-names>TM</given-names></name><name><surname>de Silva</surname> <given-names>TI</given-names></name><name><surname>McDanal</surname> <given-names>C</given-names></name><name><surname>Perez</surname> <given-names>LG</given-names></name><name><surname>Tang</surname> <given-names>H</given-names></name><name><surname>Moon-Walker</surname> <given-names>A</given-names></name><name><surname>Whelan</surname> <given-names>SP</given-names></name><name><surname>LaBranche</surname> <given-names>CC</given-names></name><name><surname>Saphire</surname> <given-names>EO</given-names></name><name><surname>Montefiori</surname> <given-names>DC</given-names></name><name><surname>Angyal</surname> <given-names>A</given-names></name><name><surname>Brown</surname> <given-names>RL</given-names></name><name><surname>Carrilero</surname> <given-names>L</given-names></name><name><surname>Green</surname> <given-names>LR</given-names></name><name><surname>Groves</surname> <given-names>DC</given-names></name><name><surname>Johnson</surname> <given-names>KJ</given-names></name><name><surname>Keeley</surname> <given-names>AJ</given-names></name><name><surname>Lindsey</surname> <given-names>BB</given-names></name><name><surname>Parsons</surname> <given-names>PJ</given-names></name><name><surname>Raza</surname> <given-names>M</given-names></name><name><surname>Rowland-Jones</surname> <given-names>S</given-names></name><name><surname>Smith</surname> <given-names>N</given-names></name><name><surname>Tucker</surname> <given-names>RM</given-names></name><name><surname>Wang</surname> <given-names>D</given-names></name><name><surname>Wyles</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus</article-title><source>Cell</source><volume>182</volume><fpage>812</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.06.043</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Kosakovsky-Pond</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2020">2020</year><source>Natural selection analysis of SARS-CoV-2/COVID-19</source><ext-link ext-link-type="uri" xlink:href="https://covid19.galaxyproject.org/evolution">https://covid19.galaxyproject.org/evolution</ext-link></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname> <given-names>TT</given-names></name><name><surname>Jia</surname> <given-names>N</given-names></name><name><surname>Zhang</surname> <given-names>YW</given-names></name><name><surname>Shum</surname> <given-names>MH</given-names></name><name><surname>Jiang</surname> <given-names>JF</given-names></name><name><surname>Zhu</surname> <given-names>HC</given-names></name><name><surname>Tong</surname> <given-names>YG</given-names></name><name><surname>Shi</surname> <given-names>YX</given-names></name><name><surname>Ni</surname> <given-names>XB</given-names></name><name><surname>Liao</surname> <given-names>YS</given-names></name><name><surname>Li</surname> <given-names>WJ</given-names></name><name><surname>Jiang</surname> <given-names>BG</given-names></name><name><surname>Wei</surname> <given-names>W</given-names></name><name><surname>Yuan</surname> <given-names>TT</given-names></name><name><surname>Zheng</surname> <given-names>K</given-names></name><name><surname>Cui</surname> <given-names>XM</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Pei</surname> <given-names>GQ</given-names></name><name><surname>Qiang</surname> <given-names>X</given-names></name><name><surname>Cheung</surname> <given-names>WY</given-names></name><name><surname>Li</surname> <given-names>LF</given-names></name><name><surname>Sun</surname> <given-names>FF</given-names></name><name><surname>Qin</surname> <given-names>S</given-names></name><name><surname>Huang</surname> <given-names>JC</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name><name><surname>Holmes</surname> <given-names>EC</given-names></name><name><surname>Hu</surname> <given-names>YL</given-names></name><name><surname>Guan</surname> <given-names>Y</given-names></name><name><surname>Cao</surname> <given-names>WC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins</article-title><source>Nature</source><volume>583</volume><fpage>282</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2169-0</pub-id><pub-id pub-id-type="pmid">32218527</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname> <given-names>B</given-names></name><name><surname>Wilks</surname> <given-names>C</given-names></name><name><surname>Antonescu</surname> <given-names>V</given-names></name><name><surname>Charles</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Scaling read aligners to hundreds of threads on general-purpose processors</article-title><source>Bioinformatics</source><volume>35</volume><fpage>421</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty648</pub-id><pub-id pub-id-type="pmid">30020410</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname> <given-names>B</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with Bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsson</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>AliView: a fast and lightweight alignment viewer and editor for large datasets</article-title><source>Bioinformatics</source><volume>30</volume><fpage>3276</fpage><lpage>3278</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu531</pub-id><pub-id pub-id-type="pmid">25095880</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname> <given-names>M</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Pagès</surname> <given-names>H</given-names></name><name><surname>Aboyoun</surname> <given-names>P</given-names></name><name><surname>Carlson</surname> <given-names>M</given-names></name><name><surname>Gentleman</surname> <given-names>R</given-names></name><name><surname>Morgan</surname> <given-names>MT</given-names></name><name><surname>Carey</surname> <given-names>VJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Software for computing and annotating genomic ranges</article-title><source>PLOS Computational Biology</source><volume>9</volume><elocation-id>e1003118</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003118</pub-id><pub-id pub-id-type="pmid">23950696</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lokugamage</surname> <given-names>KG</given-names></name><name><surname>Hage</surname> <given-names>A</given-names></name><name><surname>de Vries</surname> <given-names>M</given-names></name><name><surname>Valero-Jimenez</surname> <given-names>AM</given-names></name><name><surname>Schindewolf</surname> <given-names>C</given-names></name><name><surname>Dittmann</surname> <given-names>M</given-names></name><name><surname>Rajsbaum</surname> <given-names>R</given-names></name><name><surname>Menachery</surname> <given-names>VD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV</article-title><source>Journal of Virology</source><volume>10</volume><elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.01410-20</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>W</given-names></name><name><surname>Xu</surname> <given-names>K</given-names></name><name><surname>Sun</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><chapter-title>SARS accessory proteins ORF3a and 9b and their functional analysis</chapter-title><person-group person-group-type="editor"><name><surname>Lal</surname> <given-names>S. K</given-names></name></person-group><source>Molecular Biology of the SARS-Coronavirus</source><publisher-name>Springer-Verlag</publisher-name><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1007/978-3-642-03683-5</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname> <given-names>R</given-names></name><name><surname>Fielding</surname> <given-names>BC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesis</article-title><source>Viruses</source><volume>4</volume><fpage>2902</fpage><lpage>2923</lpage><pub-id pub-id-type="doi">10.3390/v4112902</pub-id><pub-id pub-id-type="pmid">23202509</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>McKinney</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Data structures for statistical computing in Python</article-title><conf-name>Proceedings of the 9th Python in Science Conference</conf-name><fpage>51</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.25080/Majora-92bf1922-00a</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname> <given-names>CJ</given-names></name><name><surname>Mayer</surname> <given-names>C</given-names></name><name><surname>Poch</surname> <given-names>O</given-names></name><name><surname>Thompson</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Characterization of accessory genes in coronavirus genomes</article-title><source>Virology Journal</source><volume>17</volume><elocation-id>131</elocation-id><pub-id pub-id-type="doi">10.1186/s12985-020-01402-1</pub-id><pub-id pub-id-type="pmid">32854725</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nei</surname> <given-names>M</given-names></name><name><surname>Gojobori</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions</article-title><source>Molecular Biology and Evolution</source><volume>3</volume><fpage>418</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a040410</pub-id><pub-id pub-id-type="pmid">3444411</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nei</surname> <given-names>M</given-names></name><name><surname>Kumar</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2000">2000</year><source>Molecular Evolution and Phylogenetics</source><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>CW</given-names></name><name><surname>Moncla</surname> <given-names>LH</given-names></name><name><surname>Hughes</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SNPGenie: estimating evolutionary parameters to detect natural selection using pooled next-generation sequencing data</article-title><source>Bioinformatics</source><volume>100</volume><fpage>3709</fpage><lpage>3711</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv449</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>CW</given-names></name><name><surname>Ardern</surname> <given-names>Z</given-names></name><name><surname>Wei</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>OLGenie: estimating natural selection to predict functional overlapping genes</article-title><source>Molecular Biology and Evolution</source><volume>14</volume><elocation-id>876607</elocation-id><pub-id pub-id-type="doi">10.1101/2019.12.14.876607</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>CW</given-names></name><name><surname>Ardern</surname> <given-names>Z</given-names></name><name><surname>Goldberg</surname> <given-names>TL</given-names></name><name><surname>Meng</surname> <given-names>C</given-names></name><name><surname>Kuo</surname> <given-names>C-H</given-names></name><name><surname>Ludwig</surname> <given-names>C</given-names></name><name><surname>Kolokotronis</surname> <given-names>S-O</given-names></name><name><surname>Wei</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020b</year><data-title>SARS-CoV-2 <italic>ORF3d</italic></data-title><source>GitHub</source><version designator="5bcbbd1">5bcbbd1</version><ext-link ext-link-type="uri" xlink:href="https://github.com/chasewnelson/SARS-CoV-2-ORF3d">https://github.com/chasewnelson/SARS-CoV-2-ORF3d</ext-link></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>CW</given-names></name><name><surname>Hughes</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Within-host nucleotide diversity of virus populations: insights from next-generation sequencing</article-title><source>Infection, Genetics and Evolution</source><volume>30</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2014.11.026</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>LT</given-names></name><name><surname>Schmidt</surname> <given-names>HA</given-names></name><name><surname>von Haeseler</surname> <given-names>A</given-names></name><name><surname>Minh</surname> <given-names>BQ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies</article-title><source>Molecular Biology and Evolution</source><volume>32</volume><fpage>268</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1093/molbev/msu300</pub-id><pub-id pub-id-type="pmid">25371430</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname> <given-names>S</given-names></name><name><surname>Sidney</surname> <given-names>J</given-names></name><name><surname>Sette</surname> <given-names>A</given-names></name><name><surname>Peters</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>TepiTool: a pipeline for computational prediction of T cell epitope candidates</article-title><source>Current Protocols in Immunology</source><volume>114</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1002/cpim.12</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavesi</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>New insights into the evolutionary features of viral overlapping genes by discriminant analysis</article-title><source>Virology</source><volume>546</volume><fpage>51</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2020.03.007</pub-id><pub-id pub-id-type="pmid">32452417</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plante</surname> <given-names>JA</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Xia</surname> <given-names>H</given-names></name><name><surname>Johnson</surname> <given-names>BA</given-names></name><name><surname>Lokugamage</surname> <given-names>KG</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Muruato</surname> <given-names>AE</given-names></name><name><surname>Zou</surname> <given-names>J</given-names></name><name><surname>Fontes-Garfias</surname> <given-names>CR</given-names></name><name><surname>Mirchandani</surname> <given-names>D</given-names></name><name><surname>Scharton</surname> <given-names>D</given-names></name><name><surname>Bilello</surname> <given-names>JP</given-names></name><name><surname>Ku</surname> <given-names>Z</given-names></name><name><surname>An</surname> <given-names>Z</given-names></name><name><surname>Kalveram</surname> <given-names>B</given-names></name><name><surname>Freiberg</surname> <given-names>AN</given-names></name><name><surname>Menachery</surname> <given-names>VD</given-names></name><name><surname>Xie</surname> <given-names>X</given-names></name><name><surname>Plante</surname> <given-names>KS</given-names></name><name><surname>Weaver</surname> <given-names>SC</given-names></name><name><surname>Shi</surname> <given-names>P-Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Spike mutation D614G alters SARS-CoV-2 fitness</article-title><source>Nature</source><volume>3</volume><elocation-id>2895</elocation-id><pub-id pub-id-type="doi">10.1038/s41586-020-2895-3</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2018">2018</year><data-title>R: A language and environment for statistical computing</data-title><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname> <given-names>SU</given-names></name><name><surname>Shafique</surname> <given-names>L</given-names></name><name><surname>Ihsan</surname> <given-names>A</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Evolutionary trajectory for the emergence of novel coronavirus SARS-CoV-2</article-title><source>Pathogens</source><volume>9</volume><elocation-id>240</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens9030240</pub-id><pub-id pub-id-type="pmid">32210130</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynisson</surname> <given-names>B</given-names></name><name><surname>Barra</surname> <given-names>C</given-names></name><name><surname>Kaabinejadian</surname> <given-names>S</given-names></name><name><surname>Hildebrand</surname> <given-names>WH</given-names></name><name><surname>Peters</surname> <given-names>B</given-names></name><name><surname>Nielsen</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data</article-title><source>Journal of Proteome Research</source><volume>19</volume><fpage>2304</fpage><lpage>2315</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.9b00874</pub-id><pub-id pub-id-type="pmid">32308001</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothe</surname> <given-names>C</given-names></name><name><surname>Schunk</surname> <given-names>M</given-names></name><name><surname>Sothmann</surname> <given-names>P</given-names></name><name><surname>Bretzel</surname> <given-names>G</given-names></name><name><surname>Froeschl</surname> <given-names>G</given-names></name><name><surname>Wallrauch</surname> <given-names>C</given-names></name><name><surname>Zimmer</surname> <given-names>T</given-names></name><name><surname>Thiel</surname> <given-names>V</given-names></name><name><surname>Janke</surname> <given-names>C</given-names></name><name><surname>Guggemos</surname> <given-names>W</given-names></name><name><surname>Seilmaier</surname> <given-names>M</given-names></name><name><surname>Drosten</surname> <given-names>C</given-names></name><name><surname>Vollmar</surname> <given-names>P</given-names></name><name><surname>Zwirglmaier</surname> <given-names>K</given-names></name><name><surname>Zange</surname> <given-names>S</given-names></name><name><surname>Wölfel</surname> <given-names>R</given-names></name><name><surname>Hoelscher</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transmission of 2019-nCoV infection from an asymptomatic contact in Germany</article-title><source>New England Journal of Medicine</source><volume>382</volume><fpage>970</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2001468</pub-id><pub-id pub-id-type="pmid">32003551</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabath</surname> <given-names>N</given-names></name><name><surname>Landan</surname> <given-names>G</given-names></name><name><surname>Graur</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A method for the simultaneous estimation of selection intensities in overlapping genes</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e3996</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0003996</pub-id><pub-id pub-id-type="pmid">19098983</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schirmer</surname> <given-names>M</given-names></name><name><surname>D’Amore</surname> <given-names>R</given-names></name><name><surname>Ijaz</surname> <given-names>UZ</given-names></name><name><surname>Hall</surname> <given-names>N</given-names></name><name><surname>Quince</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Illumina error profiles: resolving fine-scale variation in metagenomic sequencing data</article-title><source>BMC Bioinformatics</source><volume>17</volume><elocation-id>125</elocation-id><pub-id pub-id-type="doi">10.1186/s12859-016-0976-y</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlub</surname> <given-names>TE</given-names></name><name><surname>Buchmann</surname> <given-names>JP</given-names></name><name><surname>Holmes</surname> <given-names>EC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A simple method to detect candidate overlapping genes in viruses using single genome sequences</article-title><source>Molecular Biology and Evolution</source><volume>35</volume><fpage>2572</fpage><lpage>2581</lpage><pub-id pub-id-type="doi">10.1093/molbev/msy155</pub-id><pub-id pub-id-type="pmid">30099499</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwanhäusser</surname> <given-names>B</given-names></name><name><surname>Busse</surname> <given-names>D</given-names></name><name><surname>Li</surname> <given-names>N</given-names></name><name><surname>Dittmar</surname> <given-names>G</given-names></name><name><surname>Schuchhardt</surname> <given-names>J</given-names></name><name><surname>Wolf</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Selbach</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Global quantification of mammalian gene expression control</article-title><source>Nature</source><volume>473</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/nature10098</pub-id><pub-id pub-id-type="pmid">21593866</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sidney</surname> <given-names>J</given-names></name><name><surname>Peters</surname> <given-names>B</given-names></name><name><surname>Frahm</surname> <given-names>N</given-names></name><name><surname>Brander</surname> <given-names>C</given-names></name><name><surname>Sette</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>HLA class I supertypes: a revised and updated classification</article-title><source>BMC Immunology</source><volume>9</volume><elocation-id>1</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2172-9-1</pub-id><pub-id pub-id-type="pmid">18211710</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soubrier</surname> <given-names>J</given-names></name><name><surname>Steel</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>MS</given-names></name><name><surname>Der Sarkissian</surname> <given-names>C</given-names></name><name><surname>Guindon</surname> <given-names>S</given-names></name><name><surname>Ho</surname> <given-names>SY</given-names></name><name><surname>Cooper</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The influence of rate heterogeneity among sites on the time dependence of molecular rates</article-title><source>Molecular Biology and Evolution</source><volume>29</volume><fpage>3345</fpage><lpage>3358</lpage><pub-id pub-id-type="doi">10.1093/molbev/mss140</pub-id><pub-id pub-id-type="pmid">22617951</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suyama</surname> <given-names>M</given-names></name><name><surname>Torrents</surname> <given-names>D</given-names></name><name><surname>Bork</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>PAL2NAL: robust conversion of protein sequence alignments into the corresponding codon alignments</article-title><source>Nucleic Acids Research</source><volume>34</volume><fpage>W609</fpage><lpage>W612</lpage><pub-id pub-id-type="doi">10.1093/nar/gkl315</pub-id><pub-id pub-id-type="pmid">16845082</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavaré</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Some probabilistic and statistical problems in the analysis of DNA sequences</article-title><source>Lectures on Mathematics in the Life Sciences</source><volume>17</volume><fpage>57</fpage><lpage>86</lpage></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyanova</surname> <given-names>S</given-names></name><name><surname>Temu</surname> <given-names>T</given-names></name><name><surname>Cox</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The MaxQuant computational platform for mass spectrometry-based shotgun proteomics</article-title><source>Nature Protocols</source><volume>11</volume><fpage>2301</fpage><lpage>2319</lpage><pub-id pub-id-type="doi">10.1038/nprot.2016.136</pub-id><pub-id pub-id-type="pmid">27809316</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname> <given-names>AS</given-names></name><name><surname>Archuleta</surname> <given-names>J</given-names></name><name><surname>Feng</surname> <given-names>WC</given-names></name><name><surname>Setubal</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Missing genes in the annotation of prokaryotic genomes</article-title><source>BMC Bioinformatics</source><volume>11</volume><elocation-id>131</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-11-131</pub-id><pub-id pub-id-type="pmid">20230630</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A simple method for estimating the strength of natural selection on overlapping genes</article-title><source>Genome Biology and Evolution</source><volume>7</volume><fpage>381</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1093/gbe/evu294</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Wells</surname> <given-names>HL</given-names></name><name><surname>Letko</surname> <given-names>M</given-names></name><name><surname>Lasso</surname> <given-names>G</given-names></name><name><surname>Ssebide</surname> <given-names>B</given-names></name><name><surname>Nziza</surname> <given-names>J</given-names></name><name><surname>Byarugaba</surname> <given-names>DK</given-names></name><name><surname>Navarrete-Macias</surname> <given-names>I</given-names></name><name><surname>Liang</surname> <given-names>E</given-names></name><name><surname>Cranfield</surname> <given-names>M</given-names></name><name><surname>Han</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The evolutionary history of ACE2 usage within the coronavirus subgenus <italic>Sarbecovirus</italic></article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.07.07.190546</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilm</surname> <given-names>A</given-names></name><name><surname>Aw</surname> <given-names>PP</given-names></name><name><surname>Bertrand</surname> <given-names>D</given-names></name><name><surname>Yeo</surname> <given-names>GH</given-names></name><name><surname>Ong</surname> <given-names>SH</given-names></name><name><surname>Wong</surname> <given-names>CH</given-names></name><name><surname>Khor</surname> <given-names>CC</given-names></name><name><surname>Petric</surname> <given-names>R</given-names></name><name><surname>Hibberd</surname> <given-names>ML</given-names></name><name><surname>Nagarajan</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets</article-title><source>Nucleic Acids Research</source><volume>40</volume><fpage>11189</fpage><lpage>11201</lpage><pub-id pub-id-type="doi">10.1093/nar/gks918</pub-id><pub-id pub-id-type="pmid">23066108</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worobey</surname> <given-names>M</given-names></name><name><surname>Pekar</surname> <given-names>J</given-names></name><name><surname>Larsen</surname> <given-names>BB</given-names></name><name><surname>Nelson</surname> <given-names>MI</given-names></name><name><surname>Hill</surname> <given-names>V</given-names></name><name><surname>Joy</surname> <given-names>JB</given-names></name><name><surname>Rambaut</surname> <given-names>A</given-names></name><name><surname>Suchard</surname> <given-names>MA</given-names></name><name><surname>Wertheim</surname> <given-names>JO</given-names></name><name><surname>Lemey</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The emergence of SARS-CoV-2 in Europe and North America</article-title><source>Science</source><volume>370</volume><fpage>564</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1126/science.abc8169</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>A</given-names></name><name><surname>Peng</surname> <given-names>Y</given-names></name><name><surname>Huang</surname> <given-names>B</given-names></name><name><surname>Ding</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Niu</surname> <given-names>P</given-names></name><name><surname>Meng</surname> <given-names>J</given-names></name><name><surname>Zhu</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Sheng</surname> <given-names>J</given-names></name><name><surname>Quan</surname> <given-names>L</given-names></name><name><surname>Xia</surname> <given-names>Z</given-names></name><name><surname>Tan</surname> <given-names>W</given-names></name><name><surname>Cheng</surname> <given-names>G</given-names></name><name><surname>Jiang</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China</article-title><source>Cell Host &amp; Microbe</source><volume>27</volume><fpage>325</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2020.02.001</pub-id><pub-id pub-id-type="pmid">32035028</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>F</given-names></name><name><surname>Zhao</surname> <given-names>S</given-names></name><name><surname>Yu</surname> <given-names>B</given-names></name><name><surname>Chen</surname> <given-names>YM</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Song</surname> <given-names>ZG</given-names></name><name><surname>Hu</surname> <given-names>Y</given-names></name><name><surname>Tao</surname> <given-names>ZW</given-names></name><name><surname>Tian</surname> <given-names>JH</given-names></name><name><surname>Pei</surname> <given-names>YY</given-names></name><name><surname>Yuan</surname> <given-names>ML</given-names></name><name><surname>Zhang</surname> <given-names>YL</given-names></name><name><surname>Dai</surname> <given-names>FH</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>QM</given-names></name><name><surname>Zheng</surname> <given-names>JJ</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Holmes</surname> <given-names>EC</given-names></name><name><surname>Zhang</surname> <given-names>YZ</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>A new coronavirus associated with human respiratory disease in China</article-title><source>Nature</source><volume>579</volume><fpage>265</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2008-3</pub-id><pub-id pub-id-type="pmid">32015508</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname> <given-names>Y</given-names></name><name><surname>Lagniton</surname> <given-names>PNP</given-names></name><name><surname>Ye</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>E</given-names></name><name><surname>Xu</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19: what has been learned and to be learned about the novel coronavirus disease</article-title><source>International Journal of Biological Sciences</source><volume>16</volume><fpage>1753</fpage><lpage>1766</lpage><pub-id pub-id-type="doi">10.7150/ijbs.45134</pub-id><pub-id pub-id-type="pmid">32226295</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname> <given-names>KS</given-names></name><name><surname>Ye</surname> <given-names>ZW</given-names></name><name><surname>Fung</surname> <given-names>SY</given-names></name><name><surname>Chan</surname> <given-names>CP</given-names></name><name><surname>Jin</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 and COVID-19: the most important research questions</article-title><source>Cell &amp; Bioscience</source><volume>10</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.1186/s13578-020-00404-4</pub-id><pub-id pub-id-type="pmid">32190290</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yurkovetskiy</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Pascal</surname> <given-names>KE</given-names></name><name><surname>Tomkins-Tinch</surname> <given-names>C</given-names></name><name><surname>Nyalile</surname> <given-names>T</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Baum</surname> <given-names>A</given-names></name><name><surname>Diehl</surname> <given-names>WE</given-names></name><name><surname>Dauphin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant</article-title><source>Cell</source><volume>20</volume><elocation-id>31229</elocation-id><pub-id pub-id-type="doi">10.1101/2020.07.04.187757</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zecha</surname> <given-names>J</given-names></name><name><surname>Lee</surname> <given-names>CY</given-names></name><name><surname>Bayer</surname> <given-names>FP</given-names></name><name><surname>Meng</surname> <given-names>C</given-names></name><name><surname>Grass</surname> <given-names>V</given-names></name><name><surname>Zerweck</surname> <given-names>J</given-names></name><name><surname>Schnatbaum</surname> <given-names>K</given-names></name><name><surname>Michler</surname> <given-names>T</given-names></name><name><surname>Pichlmair</surname> <given-names>A</given-names></name><name><surname>Ludwig</surname> <given-names>C</given-names></name><name><surname>Kuster</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Data, reagents, assays and merits of proteomics for SARS-CoV-2 research and testing</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>19</volume><fpage>1503</fpage><lpage>1522</lpage><pub-id pub-id-type="doi">10.1074/mcp.RA120.002164</pub-id><pub-id pub-id-type="pmid">32591346</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>P</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>LF</given-names></name><name><surname>Shi</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Bat severe acute respiratory syndrome-like coronavirus ORF3b homologues display different interferon antagonist activities</article-title><source>Journal of General Virology</source><volume>93</volume><fpage>275</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1099/vir.0.033589-0</pub-id><pub-id pub-id-type="pmid">22012463</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>W</given-names></name><name><surname>Chen</surname> <given-names>T</given-names></name><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Eterovic</surname> <given-names>AK</given-names></name><name><surname>Meric-Bernstam</surname> <given-names>F</given-names></name><name><surname>Mills</surname> <given-names>GB</given-names></name><name><surname>Chen</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Bias from removing read duplication in ultra-deep sequencing experiments</article-title><source>Bioinformatics</source><volume>30</volume><fpage>1073</fpage><lpage>1080</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt771</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.59633.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Rokas</surname><given-names>Antonis</given-names></name><role>Reviewing Editor</role><aff><institution>Vanderbilt University</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Piontkivska</surname><given-names>Helen</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This study provides evidence for the existence of a novel gene in genomes of the SARS-CoV-2 virus that may be associated with the origin of the ongoing pandemic. The novel gene overlaps with other known genes in the SARS-CoV-2 genome and exhibits a high rate of evolutionary change. The study also offers a comparison between other overlapping ORFs identified in SARS-CoV-2 genomes, their distributions in other coronavirus species, and their rates of evolution. Given the confusion around the reported overlapping ORFs so far and the fact that these genes are quite understudied, this work is important in establishing the existence of a novel overlapping genes and will spur further analyses into its role in the SARS-CoV-2 pathogenesis.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;A previously uncharacterized gene in SARS-CoV-2 and the origins of the COVID-19 pandemic&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Patricia Wittkopp as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Helen Piontkivska (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p><p>Summary:</p><p>This manuscript describes a putative novel gene from the SARS-CoV-2 genomes that may be associated with the origin of the ongoing pandemic. While initially identified through in-silico genome sequence analysis, the authors offer additional evidence in support of the functionality of this overlapping ORF derived from Ribo-Seq data, based on the ribosomes' accumulation at the translation start site, as well as protein structure and mass spec analyses. They further examine the extent of sequence conservation of this putative ORF and the remainder of the genome across SARS-CoV-2 isolates, as well as in genomes of other coronaviruses. The results indicate while the majority of sites is subject to relaxed purifying selection, this younger overlapping <italic>ORF3c</italic> shows exhibits higher levels of nonsynonymous changes, which may potentially be linked to antibody-mediated immune response, among other factors. This is an interesting study that identifies a novel overlapping gene, <italic>ORF3c</italic>, which may have played a role in host jump. The study further offers a comparison between other overlapping ORFs identified in SARS-CoV-2 genomes and their distribution in other coronavirus species (Figure 1 and Table 1). Given the confusion around the reported overlapping ORFs so far and the fact that these genes are quite understudied, this work is important in establishing the existence of <italic>ORF3c</italic> and will spur further analyses into its role in the SARS-CoV-2 pathogenesis.</p><p>Essential revisions:</p><p>1) Title: The title is somewhat underwhelming, and can be revised to better reflect the major points of the study (e.g., emphasize novel overlapping ORF and its dynamic origin? Something like &quot;Dynamically evolving novel overlapping gene as a factor in SARS-CoV-2 pandemic&quot;, or something along those lines).</p><p>2) The authors make an important point about correct annotation and description of novel/putative ORFs within RNA virus genomes. They bring together a wide variety of different data sources to suggest that <italic>ORF3c</italic> is real, expressed, a target of the immune system and potentially under natural selection. However, many of their arguments (particularly with regards to the population genomics of SARS-CoV-2 lineages/haplotypes) lean too heavily on arguments of natural selection on particular genotypes, when simpler explanations exist (drift, founder effects and the uneven impact of virus population control across and within countries). While they acknowledge these factors, the authors nevertheless are too quick to discount them. Please avoid &quot;adaptationist&quot; language in the absence of specific analyses inferring the action of selection and ensure that all alternative explanations, including ones that do not involve selection, are adequately and fairly discussed.</p><p>3) A significant weakness in this paper is the lack of good evidence that <italic>ORF3c</italic> is expressed at the protein level. We understand that the ORF is too small to be reliably detected by mass spec, but a Western blot could be used to solve this problem. Would it be possible to provide such data? If this is not possible, it is important to ensure that readers are aware of this shortcoming of this study.</p><p>4) This paper frequently refers to other publications which are not well-respected by other members of the genomics and virology community (the Forster PNAS paper; the Bhattacharyya 2020 spike paper and others discussing the role of the D/G spike mutant).</p><p>5) The MHC prediction analysis uses NetMHCpan, which predicts CD8<sup>+</sup> T cell epitopes (presented by MHC class I), but does not consider MHC class II epitope presentation to CD4<sup>+</sup> T cells, which have been shown to be important for SARS-CoV-2 infection and which bind to different peptides in different genomic regions compared to CD8<sup>+</sup> T cells.</p><p>6) Figure 1 would benefit from having coordinates shown for all the overlapping ORFs (per Wuhan-Hu-1 reference, perhaps?)</p><p>7) Could a separate line that incorporates the ORFs listed in Table 1 be added to Figure 1? It may enhance the impact on erroneous homology in the third paragraph of the Discussion.</p><p>8) We got lost in Figure 5; perhaps, the amino acid sequences can be shown in some other way or in a separate figure/panel? It would be important to show the location of stop codons relative to their alignment positions in <italic>ORF3c</italic> and <italic>3b</italic>.</p><p>9) Discussion, end of third paragraph: this sentence isn't quite complete. S-iORF2 shows evidence of translation, and so what?</p><p>10) The manuscript has a nice list of limitations; however, we would have also liked to see a few suggestions on how the role of <italic>ORF3c</italic> could be validated, even if authors do not plan to pursue those themselves.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.59633.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Title: The title is somewhat underwhelming, and can be revised to better reflect the major points of the study (e.g., emphasize novel overlapping ORF and its dynamic origin? Something like &quot;Dynamically evolving novel overlapping gene as a factor in SARS-CoV-2 pandemic&quot;, or something along those lines).</p></disp-quote><p>Thanks for this great suggestion. We have adopted the proposed title.</p><disp-quote content-type="editor-comment"><p>2) The authors make an important point about correct annotation and description of novel/putative ORFs within RNA virus genomes. They bring together a wide variety of different data sources to suggest that ORF3c is real, expressed, a target of the immune system and potentially under natural selection. However, many of their arguments (particularly with regards to the population genomics of SARS-CoV-2 lineages/haplotypes) lean too heavily on arguments of natural selection on particular genotypes, when simpler explanations exist (drift, founder effects and the uneven impact of virus population control across and within countries). While they acknowledge these factors, the authors nevertheless are too quick to discount them. Please avoid &quot;adaptationist&quot; language in the absence of specific analyses inferring the action of selection and ensure that all alternative explanations, including ones that do not involve selection, are adequately and fairly discussed.</p></disp-quote><p>We completely agree with the reviewers. We have reworked our arguments to avoid adaptationist language, and emphasize non-selective mechanisms throughout, especially the potential roles of drift and founder effects. Three specific examples follow.</p><p>First, in the section on “Between-host evolution and pandemic spread”, we have changed the text to read as follows:</p><p>“During the first months of the COVID-19 pandemic, ORF3d-LOF increased in frequency (Table S15 in Supplementary file 1) in multiple locations (Figure 5—figure supplement 2D; Table S16 in Supplementary file 1), making this mutation a candidate for natural selection on <italic>ORF3a</italic>, ORF3d, or both (Kosakovsky-Pond, 2020). However, temporal allele frequency trajectories (Figure 5—figure supplement 2D) and similar signals from phylogenetic branch tests may also be caused by founder effects or genetic drift, and are susceptible to ascertainment bias (e.g., preferential sequencing of imported infections and uneven geographic sampling) and stochastic error (e.g., small sample sizes).”</p><p>Second, in the same section, we have also tempered our language when discussing potential driver mutations, now writing:</p><p>“Thus, while founder effects and drift are plausible explanations, it is also worth investigating whether the early spread of ORF3d-LOF may have been caused by its linkage with another driver, either C14408U (+1 variant) or a subsequent variant(s) occurring on the EP+1+LOF background (Discussion).”</p><p>Finally, in the Discussion, we have removed any mention of viral spread, hospitalization rate, etc., and instead written a full section detailing non-adaptationist explanations of the quick spread of certain variants:</p><p>“The quick expansion of ORF3d-LOF (EP+1+LOF) and its haplotype (EP+1) during this pandemic is surprising, given that a founder effect would have favored other variants that arrived earlier. […] Thus, it is possible that G25563U is neutral while a linked variant(s) is under selection.”</p><disp-quote content-type="editor-comment"><p>3) A significant weakness in this paper is the lack of good evidence that ORF3c is expressed at the protein level. We understand that the ORF is too small to be reliably detected by mass spec, but a Western blot could be used to solve this problem. Would it be possible to provide such data? If this is not possible, it is important to ensure that readers are aware of this shortcoming of this study.</p></disp-quote><p>We agree with the reviewers that a western blot with the antibody to ORF3d (previously <italic>ORF3c</italic>) would be the best way of validating its protein product. Via personal communication with Raven Kok, we were made aware that their research group at the University of Hong Kong has raised antibodies for ORF3d for such an experiment. As our group lacks the resources and expertise for western blot, and since this effort is being made by other groups, we instead focused on providing more analytical evidence from ribosome profiling. We now added new ribosome profiling results using the datasets from 5 hours post infection from Finkel et al., 2020. These new results, although not directly proving the stable presence of ORF3d protein, strongly support translation of <italic>ORF3d</italic>. Specifically, in the section on “ORF3d molecular biology and expression”, we show that ORF3d fits a pattern observed for all annotated genes, i.e., a local maximum in ribosome profiling read depth at the ribosome P-site offset of -12 nt relative to its start site (Figure 2A), and validate this approach by showing that the depth of these peaks correlates strongly (r=0.89, p=0.0004, Spearman’s rank) with protein levels measured from mass spectrometry (Figure 2B). We also conduct a frame-based analysis, showing that stalled ribosomes are uniquely enriched in the frame of ORF3d at its precise locus (Figure 2C).</p><p>With respect to mass spectrometry (MS), we have specifically discussed the limitations of this method in three places in the manuscript. First, in the section “ORF3d molecular biology and expression”, we have added:</p><p>“This result [lack of detection of ORF3d] may reflect the limitations of MS for detecting proteins that are very short, weakly expressed under the specific conditions tested, or lack detectable peptides. Even the envelope protein E is not detected in some SARS-CoV-2 studies (Bojkova et al., 2020; Davidson et al., 2020), and the only evidence for <italic>ORF3b</italic> expression in SARS-CoV comes from Vero E6 cells (McBride and Fielding, 2012).”</p><p>Second, we have also added text discussing other possibilities for validation of ORF3d translation (see response #10). Finally, we have also added further explanation in the limitations paragraph of the Discussion:</p><p>“First, we were not able to confirm the translation of ORF3d using mass spectrometry (MS). This may be due to several reasons: (1) ORF3d is short, and tryptic digestion of ORF3d generates only two peptides potentially detectable by MS; (2) ORF3d may be expressed at low levels; (3) the tryptic peptides derived from ORF3d may not be amenable to detection by MS even under the best possible conditions, as suggested by its relatively low MS intensity even in an overexpression experiment (‘ORF3b’ in Gordon et al., 2020); and (4) hitherto unknown post-translational modifications of ORF3d could also prohibit detection.”</p><disp-quote content-type="editor-comment"><p>4) This paper frequently refers to other publications which are not well-respected by other members of the genomics and virology community (the Forster PNAS paper; the Bhattacharyya 2020 spike paper and others discussing the role of the D/G spike mutant).</p></disp-quote><p>We agree, and have removed references to these controversial papers, instead replacing both with more appropriate references, Korber et al., 2020, or both Korber et al., 2020, and Yurkovetskiy et al., 2020.</p><disp-quote content-type="editor-comment"><p>5) The MHC prediction analysis uses NetMHCpan, which predicts CD8<sup>+</sup> T cell epitopes (presented by MHC class I), but does not consider MHC class II epitope presentation to CD4<sup>+</sup> T cells, which have been shown to be important for SARS-CoV-2 infection and which bind to different peptides in different genomic regions compared to CD8<sup>+</sup> T cells.</p></disp-quote><p>The reviewer raises an important point. We agree that MHC II is also critically important, particularly as antibody responses depend on the CD4<sup>+</sup> T cell response. We have therefore completed a new MHC II analysis using NetMHCIIpan, now included in Figure 3A. Briefly, full-length ORF3d also has one of the lowest CD4<sup>+</sup> T cell epitope densities, after <italic>ORF3b</italic>, <italic>ORF7b</italic>, and <italic>ORF10</italic>; moreover, the short isoform ORF3d-2 has no CD4<sup>+</sup> T cell epitopes, a significant depletion compared to both short unannotated ORFs (p=0.001) and its own amino acid content (p=0.001) (see manuscript). For continuity with the reviewers’ requests to cover all OLGs (comments #6, #7, #8, and #10), we also examined the older and more constrained <italic>ORF3c</italic> (previously ORF3h/ORF3a*), finding that <italic>ORF3c</italic> has the highest observed CD8<sup>+</sup> T cell epitope density. See the fully updated section “Protein sequence properties” and Figure 3A.</p><disp-quote content-type="editor-comment"><p>6) Figure 1 would benefit from having coordinates shown for all the overlapping ORFs (per Wuhan-Hu-1 reference, perhaps?)</p></disp-quote><p>This is a great suggestion. To address this in general (along with comments #6, #7, #8, and #10), we have now included all <italic>ORF3a</italic> OLGs in all our analyses throughout the manuscript for continuity. With respect to this specific comment and figure, we have (1) split Figure 1 into two panels, A (top) and B (bottom), with the Wuhan-Hu-1 coordinate system shown as x-axis in panel A; (2) explicitly marked out the coordinates of <italic>ORF3a</italic> and its OLGs <italic>ORF3c</italic>, <italic>ORF3d</italic>, and <italic>ORF3b</italic> next to where they appear in the diagram; and (3) provided source data and Tables S2 and S7 in Supplementary file 1, where specific coordinates for all genes can be found with respect to Wuhan-Hu-1 and our Severe acute respiratory syndrome-related coronavirus alignment, respectively.</p><disp-quote content-type="editor-comment"><p>7) Could a separate line that incorporates the ORFs listed in Table 1 be added to Figure 1? It may enhance the impact on erroneous homology in the third paragraph of the Discussion.</p></disp-quote><p>To address this, we have (1) implemented the changes discussed in response to comment #6; (2) added all OLGs from Table 1 (i.e., now including <italic>ORF3c</italic>) in Figure 1A; (3) drawn special attention to the OLGs in <italic>ORF3a</italic> by listing their coordinates in Figure 1A; and (4) made explicit reference to the updated version of Figure 4, which annotates the SARS-CoV-2 STOP codons in the region that is homologous to SARS-CoV <italic>ORF3b</italic>. Also see response #8.</p><disp-quote content-type="editor-comment"><p>8) We got lost in Figure 5; perhaps, the amino acid sequences can be shown in some other way or in a separate figure/panel? It would be important to show the location of stop codons relative to their alignment positions in ORF3c and 3b.</p></disp-quote><p>Thanks for this excellent suggestion. We have split the figure (now Figure 4) into two panels, with (A) showing the amino acid sequences and (B) showing the alignments. For <italic>ORF3b</italic>, we opted to replace the SARS-CoV amino acid sequence with that of SARS-CoV-2 (Wuhan-Hu-1), thereby emphasizing the presence of STOP codons in this ORF in the latter.</p><disp-quote content-type="editor-comment"><p>9) Discussion, end of third paragraph: this sentence isn't quite complete. S-iORF2 shows evidence of translation, and so what?</p></disp-quote><p>To address this point, we have introduced a new paragraph in the Discussion (“Although our study focuses on ORF3d, other OLGs have been proposed in SARS-CoV-2 and warrant investigation…”). We also briefly address the other overlapping genes, as requested by the reviewers in comments #6, #7, #8, and #10. This specific sentence in question now reads as follows:</p><p>“Within S, S-iORF2 (genome positions 21768-21863) also shows evidence of translation from ribosome profiling (Finkel et al., 2020), and between-host comparisons suggest purifying selection (πN/πS=0.22, p=0.0278) (Table 1). We therefore suggest that the SARS-CoV-2 genome could contain additional undocumented or new OLGs.”</p><disp-quote content-type="editor-comment"><p>10) The manuscript has a nice list of limitations; however, we would have also liked to see a few suggestions on how the role of ORF3c could be validated, even if authors do not plan to pursue those themselves.</p></disp-quote><p>This is a great suggestion. We have added the following text to the limitations paragraph in the Discussion:</p><p>“Other possibilities for validation of ORF3d include MS with other virus samples; affinity purification MS; fluorescent tagging and cell imaging; Western blotting; and the sequencing of additional genomes in this viral species, which would potentiate more powerful tests of purifying selection and a better understanding of the history and origin of ORF3d.”</p></body></sub-article></article>